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ABSTRACT  
Tuberculosis (TB) is the leading natural cause of mortality in South Africa, and the country has 
the sixth-highest TB burden in the world. Of every 100 000 South Africans, 781 are expected to 
develop TB. Even with the adoption of the Directly Observed Treatment, Short-Course (DOTS) 
strategy since 1996 and substantial investments and improvement in TB control, South Africa has 
failed to meet the TB-related targets set by the World Health Organization (WHO). The current 
burden of TB will lead to massive consequences of mortality and morbidity in the country besides 
the substantial financial implications for the health system. Considering the infectious nature of 
TB as a communicable disease, for the sake of controlling the level and spread of the disease as 
well as preventing drug resistance, adherence to treatment is essential. Moreover, the burden of 
non-adherence to TB treatment has been affirmed as one of the primary challenges facing global 
control of TB pandemic. The accessibility of needed care influences the adherence to treatment 
and in a situation in which non-adherence is the consequence of unjust and avoidable forces, the 
equity issue inflates its importance. Both barriers and facilitating factors to access and adherence 
to TB treatment are affected by different social determinants of health, inclusive of gender.  
Generally, the gender aspects of access to TB services have been an overlooked research area, 
and insufficient attention has been given to this aspect of TB control; although a number of 
previous studies, which had attempted to examine the association between gender and access 
barriers to TB treatment in different contexts, reported gender as a crucial factor in access to TB 
services. Hence, this dissertation aimed to explore the gender-based inequalities in access and 
adherence to TB services in South Africa, from the perspective of TB patients.  
This study relies on data drawn from the Researching Equity in Access to Health Care (REACH) 
project. Applying a comprehensive framework of access, interviews were conducted with 1229 
TB patients from four health sub-districts in South Africa, to assess gender-related inequalities 
across the access dimensions of affordability, acceptability and availability of TB services. 
Descriptive statistics were computed, and comparisons of access barriers and adherence 
between men and women were explored using multivariate linear and logistic regressions. Based 
on the results, there was no significant association between levels of adherence and gender (all 
p-values> 0.05). Among availability-related variables, men spent significantly less time at the 
clinic to fetch TB medication (coefficient, -7.06; 95% CI, [-13.5, -0.7]); however with regards to 
affordability-related variables, men were significantly less likely to receive a disability  grant (AOR, 
0.48; 95% CI, [0.36, 0.63]), and among acceptability-related variables men were significantly less 
likely to judge the length of queues to be too long or the cleanliness of the facility to be sub-
standard (AOR, 0.69; 95% CI, [0.52, 0.91], and AOR, 0.67; 95% CI, [0.46, 0.97], respectively). 
Overall, our findings suggest that there is no association between the level of adherence to TB-
treatment and gender. Moreover, there was no evidence of systematic gender-based disparities 
in access to TB services. However, the findings reveal concerns about the condition and 
cleanliness of health facilities that may impact the patients' adherence and be a barrier, 
specifically, in women's use of TB services.  
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Background  
Introduction 
Tuberculosis (TB) - an old disease that has distressed the human race for more than 4 000 years 
- remains a pressing public health concern (Zaman, 2010; Krishnan et al., 2014). In South Africa 
regardless of applying the Directly Observed Treatment, Short-Course (DOTS) strategy since 1996 
and substantial investments and enhancements in TB control, the case detection rate is still far 
from the goals defined by the World Health Organization (WHO). With 450 000 new TB infections 
annually, TB is anticipated to bring many repercussions on both mortality and morbidity of South 
Africans along with enormous financial consequences for the health system (Foster et al., 2015; 
SANAC, 2017). The burden of non-adherence to TB treatment has been affirmed as one of the 
primary challenges facing global control of TB pandemic (Van den Boogaard et al., 2011). In a 
situation where non-adherence to treatment is the consequence of unjust and avoidable forces, 
equity issue inflates its significance. Although TB services are free at the point of use in South 
African public health facilities, much is unknown about overall barriers in access to TB services 
and their association with treatment adherence. Gender, as a social determinant of health, has 
been reported to impact the access and adherence to TB services in other settings, while gender-
related barriers to TB access have been an under-researched area in South Africa. This study aims 
to explore these barriers as well as the gender-based differences of perceived barriers from the 
perspective of TB patients who enrolled in DOTS in South Africa. The following section introduces 
the overall methodological approach to the study. It represents the study design, the study 
setting and data sources in addition to the methods used in data analysis.  
The Concept of Health Equity as a Global Challenge 
Health inequalities are much-discussed issues in current health policy landscape, where massive 
inequalities in health within and between communities, societies, and geographical regions are 
debated as a significant challenge to the world (Marmot, 2005; Coburn, 2007; Ong et al., 2009). 
The matter of addressing health inequalities was first expressed in 1978 at the World Health 
Organization's Alma Ata Declaration (Ong et al., 2009; WHO, 2015). The concern for immediate 
action to advance the health of all citizens of the world through governmentsˈ policies, health 
and development workersˈ actions, and the world community was voiced within the declaration 
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(WHO, 2015). In 1980, all member states of the World Health Organization (WHO) European 
Region agreed on a joint health policy by which the first target was involved in equity: “By the 
year 2000, the principal target of WHO as well as governments is to provide a level of health 
which will allow all the people of the world to lead a productive life, both economically and 
socially” (WHO, 1985; Whitehead, 1991, p.3). Equity is an ethical concept which means social 
fairness and is rooted in principles of distributive justice (Braveman and Gruskin, 2003). 
According to WHO definitions, there is a considerable difference between inequality and inequity 
in health. The term inequity is assigned to disparities in health which are not merely unfair and 
unjust but are unnecessary and avoidable as well (Whitehead, 1991), while health inequalities 
either are related to biological differences and free choices or they are attributed to the external 
environment and conditions which are not controllable by individuals. In the case of biological-
related differences, the health inequalities are unavoidable; and it is impossible or unacceptable, 
either ethically or ideologically to change these; while in terms of environmental-related 
inequalities the uneven distributions might be unnecessary and avoidable, consequently the 
rising health inequalities also breed inequity in health (Kawachi et al., 2002). 
In the light of the nature of equality, it is noteworthy that equality in health is an essential 
reference point in endeavours to achieve greater equity in health. Particularly given that health 
inequalities are extensive and often influence the social group who are already deprived (for 
instance, on account of being poor, women, or members of a disenfranchised religious, racial, or 
ethnic group) (Braveman and Gruskin, 2003; Ong et al., 2009). Evidence shows that higher 
premature mortality rates, suffering from a higher burden of disease as well as lower survival 
chances, higher burdens and earlier onset of diseases along with increased disability among 
certain groups are in existence all around the world, across various social as well as political 
systems (Whitehead, 1991). While health is crucial to welfare and to overcoming other effects of 
social disadvantages, health inequalities consistently put groups of people who are already 
socially deprived at a further disadvantage by virtue of their health. For example, with respect to 
out-of-pocket (OOP) payments, the poor are forced into spending large amounts of their 
restricted incomes on health care, and they may end up with deficient resources to shelter and 
feed themselves (Braveman and Gruskin, 2003; O’Donnell et al., 2008). 
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Since the 1980s, health equity has become a progressively favoured research topic in health field 
so that by the end of the 1990s, many policymakers, governments, nongovernmental 
organizations (NGOs), donors, and international organizations had put equity in health care at 
the top of their health-related agendas (O’Donnell et al., 2008). In the last few years, with regard 
to emergence of interest in broad-based, context-specific primary health care as well as universal 
health coverage (UHC), tagging equity in health and access to health services have been counted 
as an encompassing goal for health systems across the globe (Ong et al., 2009; Gauld et al., 2012). 
In the face of all challenges, the ray of hope exists in the capacity of carefully designed and 
managed health systems which are capable of improving health equities through providing 
improved financial, cultural and physical access. Equitable health systems offer various benefits 
to society, such as broader life security and well-being as well as the assurance of care during the 
sickness period (Gilson et al., 2007). 
Gender Inequity in Health   
Gender inequality and inequity are among the basic structures of social hierarchy which inform 
how people are born, grow, live, and die. Gender is a powerful determinant of nearly all health 
outcomes. Gender inequalities in health, which hurt the health of women and girls all around the 
world are related to the fact that women endure nonfatal, disabling physical and mental diseases 
more than men, so despite having longer life expectancy, women are more likely to live fewer 
years in good health (Sen et al., 2007; Borrell et al., 2014). Even though gender inequality gives 
men substantial benefits over assets, power, and authority, it can damage men's overall health, 
as these advantages come with a cost to their mental and emotional health that are related to 
risky behaviours and decreased life expectancy (Sen et al., 2007).  
Gender differences in health differ in magnitude across various health states. Several health 
conditions are driven mainly by biological sex1 differences while others are the consequence of 
socialising women and men into gender roles supported by masculine and feminine norms, and 
advantages that power relations give to men, that negatively affect the health of both genders. 
                                                          
1 “Sex” is a biological construct inferred from biological characteristics implementing sexual reproduction while “Gender” 
attributes to a social construct respecting culture-bound roles, conventions, and behaviours for, along with relations between, 
boys and girls as well as women and men (Krieger, 2003) . 
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Numerous health conditions reflect a consolidation of gendered social determinants along with 
biological sex differences. In order to understand this different exposure and vulnerability, 
considering the roles of biological difference and social bias is crucial (Denton et al., 2004; Sen et 
al., 2007). 
Gender relations, as experienced in everyday life and the daily business of well-being or ill-being, 
are founded on basic structures that govern how power is rooted in the social hierarchy. Gender 
relations of power, which are disparate, complex, and framed in history, lead to the root causes 
of gender inequality and are amongst the most important social determinants of health (Sen and 
Östlin, 2008; Marmot et al., 2012). These relations ascertain if health needs are recognised, 
whether people have control over their lives and health condition, and whether they can claim 
their rights (Sen and Östlin, 2008). In order to describe gender power relations, various forms of 
discrimination and bias along with consequent injustice and inequalities should be considered. 
In other fields aside from health, the concept of gender equality has been used as a basis for 
notions of “gender justice” and “gender equity”; in such cases according to the extent that 
inequalities between women and men are the product of social power relations, they are likely 
to be innately unfair and biased. However, as a result of the confounding effect of biology, the 
same position is barely held within the field of health. Additionally, inequality of health outcomes 
can be a sign of gender injustice, since it may demonstrate that women's biology-specific needs 
are not sufficiently recognised. Therefore, gender equity in health is not solely premised on 
uniformity but stands precisely on the basis of the absence of bias (Sen et al., 2007). 
Gender systems have various features that are different across distinct societies. The concept of 
gender also intersects with racial and ethnic hierarchy, economic inequalities, disparities based 
on sexual orientation, and several other social tags. Women may own inferior land, affluence and 
possessions in nearly all societies; nevertheless, bear higher burdens of work with regards to 
ensuring the survival, reproduction and security of other household members while the majority 
of this workload is imperceptible in economic commentaries (Dijkstra and Hanmer, 2000; Sen 
and Östlin, 2008). 
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Cultural beliefs, norms of behaviour, and laws preserve Women's status as lower beings and 
second-ranked citizens, in many societies. On the other hand, men generally enjoy greater 
wealth, jobs of higher status, better education, greater political power, and less behavioural 
restrictions (Dijkstra and Hanmer, 2000). Moreover, in different parts of the world, men exercise 
power over women; they make decisions on behalf of women, also control their access to 
resources, and influence their behaviour through socially endorsed violence. However, not all 
men exercise power over all women; gender power relations intersect with age as well as the 
other social stratifiers inclusive of race, class, and ethnicity. Comprehensively, physical and 
psychological health of girls, women, transgender/intersex people, as well as boys and men can 
be affected by gender power relations (Sen and Östlin, 2008; Lee and Sadana, 2011). 
Gender systems, structural processes and their interaction, simultaneously establish the 
gendered structural determinants of health. The interaction between gender systems and 
structural processes such as improving literacy and education, demographic change in rates of 
birth and death, globalisation (including its effects on labour forces, policy space, health systems, 
and violence), and enhancing human rights aims to change the effects of gender hierarchies on 
people's health (Sen and Östlin, 2008; Macpherson et al., 2012).  
Tuberculosis – The Global Landscape 
Worldwide, TB is the dominant cause of death from a single infectious agent. TB infection, as an 
endemic airborne infectious disease, is transmitted through interaction between exposed 
individuals and infective sources within enabling socio-environmental contexts. As an airborne 
pathogen, the transmission probability of TB is driven by the volume of air inhaled from an 
infected source and the concentration of Mycobacterium tuberculosis-containing breathable 
particles (doses) per volume of air (Issarow et al., 2015; 2018). In 2016, based on WHO estimates, 
1.3 million TB deaths among HIV-negative1 people and approximately 374 000 deaths among 
HIV-positive people were reported. Of the estimated 10.4 million incident cases, most occurred 
in the WHO South-East Asia Region (45%), the WHO African Region (25%), and the WHO Western 
Pacific Region (17%); while the WHO Eastern Mediterranean Region (7%), the WHO European 
                                                          
1 Human Immunodeficiency Virus 
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Region (3%) along with the WHO Region of the Americas (3%) had the fewest cases of TB (WHO, 
2017b). From the reported statistics 35% were female, 90% were adults, and 10% (74% in Africa) 
were HIV infected people (Ankrah et al., 2017; WHO, 2017b). According to the WHO (2017), in 
several countries, there is a gap between the statistics on notified TB cases and TB incidence due 
to under-diagnosis in conjunction with underreporting of TB cases in those settings, while in 
countries with ultramodern national surveillance systems almost all the new TB cases are 
diagnosed and registered. In order to quantify the underreporting level and provide an 
acceptable proxy for TB incidence, national TB inventory studies can be used (WHO, 2017b). 
Currently, drug-resistant TB (DR-TB) is a significant public health concern in many countries. 
Globally, three groups of DR-TB are used in observation and treatment: rifampicin-resistant TB 
(RR-TB), multi-drug resistant TB (MDR-TB) and extremely drug-resistant TB (XDR-TB). RR-TB and 
MDR-TB require therapy with a second-line1 regimen while MDR-TB is resistant to most powerful 
anti TB drugs: rifampicin and isoniazid (WHO, 2016b). Extensively drug-resistant TB (XDR-TB) is in 
MDR-TB category which is resistance to the two most important classes of medicines in an MDR-
TB regimen: at least one fluoroquinolone, and a second-line injectable agent (amikacin, 
capreomycin or kanamycin)(WHO, 2017b). 
Since 1993, when tuberculosis was recognised as a worldwide public health problem, WHO 
launched the DOTS strategy, to improve patient adherence (Lawn and Zumla, 2011). International 
goals for reducing the epidemiological burden of TB had been set for 2015 and 2050 in the 
framework of the Millennium Development Goals (MDGs) along with the Stop TB Partnership 
(Glaziou et al., 2015). DOTS - by focusing principally on detection as well as effective treatment 
of infected cases - was the dominant strategy through which the Global Plan to Stop TB and 
WHO's Stop TB Campaign were designed to lead national TB policies to reach the TB-related 
MDGs. The set target was lowering prevalence and TB-related mortality by 50% between 1990 
and 2015, and reversing the rising TB incidence rates (Lawn and Zumla, 2011). The DOTS strategy 
was relying on five essential constituents: (1) government promptness concerning consistent TB 
                                                          
1 Some of the TB drugs, known as first-line TB drugs, are merely prescribed for the treatment of new patients who are improbable 
to have resistance to any of the TB medications. On the other hand, the second-line TB drugs are only used for the treatment of 
DR-TB (WHO, 2010). 
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control operations; (2) diagnosis of TB cases among symptomatic patients throughout sputum 
smear microscopy; (3) a standardised directly observed treatment (DOT) regimen for all detected 
sputum smear-positive cases; (4) perpetual supply of TB drugs and; (5) a standardised monitoring 
system that allows evaluation of treatment results for TB patients as well as the TB control 
programme (WHO, 1999; Uplekar and World Health Organisation, 2006). Although the social 
consequences and the costs (direct and indirect) of TB are catastrophic for patients, their families, 
and community on a broader scale, TB treatment is reported as one of the most cost-effective 
interventions which can reduce transmission if applied early in the disease course. Moreover, it 
has the potential to generate economic benefits that are ten times the level of health care 
investment (Laxminarayan et al., 2009; Lönnroth et al., 2010; Hargreaves et al., 2011).  
The successes of the DOTS strategy should not be overlooked. During 1995-2008, 43 million 
people received TB treatment under DOTS, and 36 million were cured. The rate of TB case 
detection increased about six-fold globally, and the rate of case-fatality halved from 8% to 4%. In 
2006, after one decade of DOTS implementation, the new Stop TB Strategy and the Global Plan 
to Stop TB were introduced to tackle critical challenges concerning TB control (Lawn and Zumla, 
2011). In 2015, based on WHO tuberculosis report, the MDG 6 goal of halting and reversing TB 
incidence had been reached on a global basis, in 16 of 22 high-burden settings which accounted 
for about 80% of TB cases. Moreover, the global rate of TB incidence had decreased by an average 
of 1.5% per year since 2000 and was 18% lower than the level of 2000. However, the reported 
global total number of TB cases in 2015 was higher than the previous years which reflected an 
improvement in national data rather an actual increase in disease burden (WHO, 2015). Despite 
all these achievements, TB incidence was not falling fast enough to reach future targets, and 
global investments and activities were insufficient to end the global TB epidemic. Hence, TB 
remained as one of the dominant causes of death globally (Raviglione and Sulis, 2016; WHO, 
2016a). Two thousand fifteen was the year of conversion of the Stop TB Strategy to the End TB 
Strategy and also of the MDGs to a new stage of Sustainable Development Goals (SDGs) (WHO, 
2015). Three high-level indicators of the End TB Strategy are as follows: (1) the absolute number 
of TB death; (2) the TB incidence rate; and (3) the proportion of TB patients who experience 
catastrophic costs which are caused by TB disease. Years 2030 and 2035 have been set as targets 
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for these indicators along with the years 2020 and 2025 as milestones, while the target set for 
2020 is 20% reduction in TB incidence and 35% decrease in the absolute number of TB-related 
death (WHO, 2016a). 
Controlling the TB pandemic encounters a number of setbacks, mainly inclusive of: (1) the HIV-
TB co-infection; (2) the emergence of the MDR-TB; (3) high number of unknown TB cases as a 
result of weak health systems, which can be responsible for continuous TB transmission; (4) 
insufficient financial resources and; (5) lack of adequate intensified research on new diagnostics, 
medications and preventive interventions (Raviglione and Sulis, 2016). 
South Africa: General Overview  
The history of South Africa is permeated with discrimination on the basis of gender and race. 
Since April 1994, after democratization of South Africa, the elected government has taken a 
number of steps with regard to reversing the consequences of apartheid legacy that was mostly 
described by extreme unjustified inequalities in health and other development policies that were 
unevenly focused on securing the white population's benefits (Coovadia et al., 2009). 
Fragmented, racially segregated, and increasingly privatised health care services were the 
essential characteristics of the apartheid regime (Chetty, 2007). Nowadays, South Africa, as a 
multiracial democracy, is home to nearly 57.7 million people, inclusive of 80.9% Black Africans as 
majority along with minority groups of Colored (8.8%), White (7.8%), and Indian/Asian (2.5%), 
while 62.9% of the reported population is urban (Coovadia et al., 2009; Statistics South Africa, 
2018a; The World Bank, Statistics SA, 2018). 
Regarding economic growth, South Africa has experienced an average of 2.82% Gross Domestic 
Product (GDP) Growth Rate from 1993 to 2018, reaching the highest of 7.60% in 1994 and lowest 
of -6.10% in 2009 (SARB, 2018). In 2017, South Africa's Gross Domestic Product (GDP) Per Capita 
in PPP1 (purchasing power parity) terms was estimated US$ 13,498 (The World Bank, 2018), while 
                                                          
1 Gross Domestic product (GDP) Per Capita in PPP is gross domestic product converted to international dollars applying the 
purchasing power parity rates. GDP at purchaser prices is defined as the sum of gross value added by all resident producers in 
the economy added to any product taxes and minus any subsidies which is not combined with the value of the goods (World 
Bank, 2018). 
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the country has obtained a Global Competitive Index (GCI)1 score of 4.32 putting it in the 61st 
position of 137 countries and has remained as one of the superior competitive countries in Sub-
Saharan Africa (Schwab, 2017). Notwithstanding positive economic growth, South Africa's 
Human Development Index (HDI)2 value for 2015 set the country in the medium human 
development rank, ranked at 119th of 188 different countries and territories (UNDP, 2016b). 
Recent evaluations have revealed that 27.7% of the South African workforce is unemployed, 
which has an adverse effect on poverty and equality. This high level of unemployment is 
connected with various factors such as gradual job creation due to slow economic growth; racial 
and gender discrimination in the labour market as a lasting legacy of apartheid; unskilled 
workforce and spatial or geographical factors which impact on labour market outcomes. 
Moreover, according to the World Bank statistics, approximately half of South Africans are poor 
based on the national upper-bound poverty line of ZAR 992 per person per month in 2015 prices. 
Over the past two decades, South Africa has made strides in poverty reduction; however, high 
inequality is a hindrance in this regard, and high level of poverty (for an upper middle-income 
country) persists as a critical challenge for the country (The World Bank, Statistics SA, 2018).     
Regarding gender-based discrimination, South Africa had a Gender Inequality Index (GII)3 value 
of 0.394, placing it in the 90th position of 159 countries in the 2015 index (UNDP, 2016a). This 
indicator reveals the fact that despite all the national commitment and improvement since 
democratisation, there is still a considerable gender gap in the country. 
Since the birth of South African democracy in 1994, decreasing inequality and poverty has been 
the primary concern of the country's development programmes and policies: from the 
Reconstruction and Development Programme (RDP) in 1994 to the latest National Development 
Plan: Vision 2030 (NDP). As a redistributive technique, the government has used the ‘social wage’ 
                                                          
1 Global Competitive Index (GCI) expresses the level of benefits that can be obtained by an economy through measuring the 
elements and institutions by both empirical as well as theoretical studies which determine improvements in productivity and 
economic growth, in the long term (Schwab, 2017). 
2 Human Development Index (HDI) is a summary measure which appraises the progress in three primary dimensions of human 
development: access to education, life expectancy, and standard of living (UNDP, 2016b). 
3 Gender Inequality Index indicates gender-related inequalities in three scopes inclusive of economic activity, reproductive health, 
and empowerment. It also might be elucidated as the loss in human development as the result of disparities among male and 
female achievements in those three mentioned scopes. The value of GII varies in the range from 0 to 1, with 0 being 100% equality, 
and 1 being 100% inequality, meaning that women fare poorly compared to men. (UNDP, 2016a). 
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to enhance the security of the lives of the poor as well as improving their cost of living through 
providing free primary health care services; child support and old age grants; no-fee paying 
schools; and free essential services including sanitation, electricity, and water to impoverished 
households (The World Bank, Statistics SA, 2018). Despite the fact that these policies and agendas 
have provided some relief from the effects of unemployment and poverty since 1994, the country 
continues to face the challenge of high poverty, high unemployment, and high inequality. The 
Gini coefficient1, as the measure of inequality, increased from 0.56 in 1995 to 0.63 in 2015, which 
is the maximum in the world. By different measures, South Africa has been reported as the most 
unequal country in the world: not only consumption expenditure inequality is high, but also 
inequality of opportunity is among the highest in the world (The World Bank, Statistics SA, 2018). 
Horizontal inequalities2 between racial groups are also apparent in the distribution of resources, 
especially with regards to lower economic classes who, in the vast majority, are black, poor and 
with limited access to resources and opportunities (Meiring et al., 2018). 
South Africa – Health Status Indicators 
In defiance of its economic position as an upper-middle income country along with significant 
social progress such as transforming the public health system to a comprehensive national 
service, the wellbeing and health of the majority of South Africans are still afflicted with the 
persistent burden of illness. This situation roots in weak management and major flaws in 
leadership and stewardship which have failed in the implementation of so-called good policies 
(Coovadia et al., 2009; Mayosi et al., 2014). In addition to the poverty-related diseases inclusive 
of maternal death, malnutrition, and infectious diseases which continue to be a widespread 
problem, the burden of non-communicable diseases is increasing as well (Coovadia et al., 2009). 
In 2016, HIV/AIDS, lower respiratory tract infections, and road injuries were reported as top three 
causes of disability-adjusted life years (DALYs)3 among South Africans (Hay et al., 2017).  
                                                          
1 Gini coefficient is the most frequently used assessment of inequality varying from 0 to 1, by attributing 0 to total equality 
(Coovadia et al., 2009).  
2 Horizontal inequality refers to the political and economic inequalities between “culturally”-delineated groups (Stewart, 2002). 
3 Disability-adjusted life years (DALYs) for a disease or health condition is a measure of the sum of years of potential life lost due 
to premature mortality and the years of productive life lost because of disability (WHO, 2018). 
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According to South African health indicators, regardless of reported progress and improvements, 
not all the health-related MDGs were achieved (Statistics South Africa, 2015). Life expectancy in 
2017 for South African females was 66.7 years and 61.2 years for males (Statistics South Africa, 
2017a), having decreased from 1990 when it was 72.3 years for females and 67.1 years for males 
(Institute for Health Metrics and Evaluation, 2018). According to Statistics South Africa, the 
number of registered deaths has increased from 317 872 in 1997 to 456 612 in 2016, with an 
observed peak of 606 239 deaths in 2007 (Statistics South Africa, 2018b). The gendered statistics 
show a decrease in the percentage of male deaths from 55.9% in 1996 to 52.7% in 2016 while 
the percentage of female deaths has increased from 44.1% in 1997 to 47.3% in 2016 (Statistics 
South Africa, 2018b). The reported Infant Mortality Rate (IMR) and the Under-five Mortality Rate 
(U5MR) for 2016 were 34/1000 live births and 43/1000 live births, respectively, which has 
decreased compare to reported rates of 45/1000 live births for IMR and 57/1000 live birth for 
U5MR in 1990. These statistics indicate that the country failed to achieve the Millennium 
Development target 4 of reducing the under-five mortality rate by two-thirds from 1990 to 2015 
(Statistics South Africa, 2015; UN IGME, 2017).   
The high burden of communicable disease, particularly HIV/AIDS and TB, is one of the greatest 
challenges of the South African health system (SANAC, 2017). Based on 2018 mid-year reports, 
approximately 13.1% of the total population is HIV-positive and the prevalence of HIV/AIDS 
among adults (aged 15 to 49 years) is reported as 19.0% (Statistics South Africa, 2018a). Indeed, 
nearly one in five people living with HIV globally are in South Africa, although the rate at which 
South Africans are being infected is estimated to be decreasing from 1.9% in 2002 to 0.9% per 
annum in 2017 (SANAC, 2017; Statistics South Africa, 2017a). Moreover, South Africa has the 
sixth highest TB incidence globally (SANAC, 2017). In 2015, at an incidence of 834 per 100 000 
people and an estimated 454 000 new diagnoses (63% in people living with HIV), TB was the 
major natural cause of mortality in the country (Statistics South Africa, 2016; Smith et al., 2018). 
There has been only a modest decline in new cases since 2012, while MDR-TB is an expanding 
problem; with the number of MDR-TB cases doubling during 2007-2012. The majority (about 
57%) of TB cases and TB-related deaths in South Africa occur in those infected with HIV (WHO, 
2016b). Since 2012, South Africa has advanced towards controlling the epidemics of HIV and TB, 
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such that new HIV infections dropped from 360 000 in 2012 to 270 000 in 2016, with a remarkable 
advance in preventing mother-to-child HIV transmission. The South African health system has 
supported the most prominent antiretroviral therapy (ART) programme in the world, as 
approximately 3.7 million people initiated on ART before December 2016, leading to a 
considerable rise in national life expectancy from 58.3 years in 2011 to 62.4 years in 2015 (SANAC, 
2017; Shearer et al., 2017). In order to achieve the global targets as well as the national targets, 
South Africa has set the National Strategic Plan (NSP) for HIV, TB and STIs1 2017-2022, as its 
fourth plan (SANAC, 2017). 
Non-communicable diseases (NCDs) including cardiovascular diseases (CVDs), diabetes, chronic 
respiratory disease and cancers are also dominant factors in the high burden of disease and 
premature mortality in South Africa, where the probability of death due to NCDs between ages 
30 and 70 years is 27% (Gray and Vawda, 2017). The risk factors for NCDs are preventable and 
mainly include tobacco use, high consumption of alcohol, obesity, unhealthy diet, and physical 
inactivity (Caleyachetty et al., 2015; Libman et al., 2015; WHO, 2017a). In South Africa, unhealthy 
dietary factors and physical inactivity are two of the most critical risk factors for NCDs (Gray and 
Vawda, 2017). South Africa has experienced an epidemiological change with deaths arising 
mainly from non-communicable diseases. During 2011–2016, there had been a remarkable 
change in the leading causes of death away from infectious diseases towards non-communicable 
diseases; in 2016, nearly 57% of total reported deaths were caused by NCDs (Statistics South 
Africa, 2018b). In 2016, of the natural leading causes of mortality in South Africa, approximately 
60% of diseases belong to the NCD category, resulting in nearly 117 400 deaths through: (1) 
diabetes mellitus (5.5% of total deaths); (2) other forms of heart disease (5.1% of total deaths); 
(3) cerebrovascular diseases (5.1% of total deaths); (4) hypertensive diseases (4.4% of total 
deaths); (5) ischaemic heart diseases (2.8% of total deaths); and (6) chronic lower respiratory 
diseases (2.8% of total deaths) (Statistics South Africa, 2018b). 
The effect of chronic non-communicable disease expands not only to the individuals as patients 
but also to their households and the health system. These groups of diseases are likely to affect 
                                                          
1 Sexually transmitted infections 
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individuals in their most economically productive years, causing a reduction in their household 
earning capacity due to a deducted ability to undertake productive labour (Puoanei et al., 2008). 
Moreover, the treatment of chronic diseases puts a heavy burden on the already afflicted health 
system primarily as a result of the durability of treatment as well as the related financial 
expenditures (Puoanei et al., 2008). In more recent years, the South African government has 
made some progress in the control of NCDs through launching new guidelines as well as disease 
prevention and health promotion policies to assist health care workers and facilities who are 
active in NCD care. Nonetheless, community-level management and prevention need to be 
enhanced to reach the SDGs of diminishing premature NCD mortality by one-third by 2030 
globally (Gray and Vawda, 2017).  
South Africa, within the context of a country in the thick of change, is experiencing one of the 
highest burdens of violence worldwide (Bola et al., 2016). The victims of interpersonal violence 
are often acutely injured and require a high level of specialist investigation as well as surgical 
care, hence the physical and psychological injuries as the consequence of the violent crime place 
substantial financial burden on the South African health system and are the fourth growing public 
health crisis after HIV, TB, and maternal health care (Bola et al., 2016; Wyatt et al., 2017). In the 
past seven years, the proportion of mortality as a result of external causes of death has increased. 
In 2016, according to Global Burden of Disease (GBD) statistics, road injury and violence were 
respectively described as the third and fourth causes of disability-adjusted life years (DALYs) 
among the South Africans (Hay et al., 2017; Statistics South Africa, 2018b). Furthermore, assault 
with 1.7% and transport accidents with 1.4% of all causes of death are among the top five 
external causes of deaths in the country (Statistics South Africa, 2018b).   
Despite the fact that the South African constitution guarantees the right to health, more than 
two decades after democracy, immense health inequities persist in the country (Coovadia et al., 
2009). There is considerable variation in South African health status based on race, level of 
education, gender, income, geographical and even residential location (Obuaku-Igwe, 2015). By 
way of illustration, national prevalence estimates for HIV indicate that Whites and Indian/Asian 
population have the lowest prevalence of the disease (with 1.1% and 0.8%, respectively), while 
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the highest prevalence is reported among Black Africans (16.6%) (Human Sciences Research 
Council, 2018). In the case of the TB loss to follow-up rate by province, only KwaZulu-Natal 
achieved the national target of 5.4% in 2015, while the Western Cape had three districts with the 
loss to follow-up rates higher than 12.5%, which was far beyond the set target (Health Systems 
Trust, 2017). Moreover, large gender differentials in health between men and women continue, 
such that the reported mortality is approximately 1.12 times higher in men than in women, 
although the HIV infection rate is higher for women compared to men. Moreover, according to 
the WHO Global TB Report, the incidence of TB was higher among male patients 
than among females, as approximately 187 000 men and 135 000 women fell ill with TB in South 
Africa in 2017 (Human Sciences Research Council, 2018; Statistics South Africa, 2018b).  
The noticeable disparities in the rates of mortality and diseases in the country reveal inequality 
in access to essential living circumstances as well as other social determinants of health including 
sanitation for the impoverished and the inequity between genders (Coovadia et al., 2009; Mayosi 
et al., 2012). Even though progress has been made in access to basic education, piped water, 
electricity, and social protection, persistence of inadequate economic growth, free-market 
policies, corruption, swift urbanization, migration, and mismanagement of public services by the 
post-apartheid government have widened the disparities; hence most South Africans remain 
harshly disadvantaged with deficient access to health services (Mayosi et al., 2012; Benatar, 
2013). 
Tuberculosis in South Africa 
South Africa, where there is a high prevalence of HIV, has the sixth highest TB incidence globally 
(SANAC, 2017). Currently, TB is the leading cause of mortality in the country. Around 438 000 
South Africans acquired TB in 2016 of whom 182 000 were women, and 256 000 were men. 
(Statistics South Africa, 2016; Smith et al., 2018). In contrast to the global picture, the majority 
(about 57%) of new TB cases and TB-related deaths in South Africa occur in those infected with 
HIV (WHO, 2016b). Besides, approximately 42% of reported new TB cases are estimated to be in 
women (WHO, 2017b). In recent years, the rate of successful treatment among new smear-
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positive and smear-negative1/extra-pulmonary2 TB patients has improved while among 
retreatment cases, outcomes remain poor. Furthermore, approximately 25% of smear-positive 
TB cases experience initial loss to follow-up, which leads to continuing transmission and a higher 
risk of death (Churchyard et al., 2014). 
The emergence of DR-TB has been a significant contributor to the high burden of TB in South 
Africa (Gray and Vawda, 2017). In order to address this epidemic, access to drug-sensitivity 
testing for all TB patients as well as effective second-line anti-tuberculosis treatment for all 
diagnosed drug-resistant TB patients is required (Gray and Vawda, 2017). Moreover, South Africa 
deals with the third highest number of DR-TB patients worldwide, after India and Russia. In 2015, 
12 527 cases were reported to be enrolled on treatment, which was fourfold the figure reported 
for 2007. The DR-TB therapy results are unsatisfactory, with a success rate of about 50% (Gray 
and Vawda, 2017). More precisely, from the RR-TB cases reported to have begun second-line 
treatment in South Africa, only 48% of MDR-TB cases and 24% of XDR-TB cases who started 
treatment in 2013 were recorded as successfully treated (Gray and Vawda, 2017). Worldwide, 
the majority of reported cases of XDR-TB, as the most resistant form of TB which is hard to treat 
and affiliated with high mortality rates and failure of therapy, are from South Africa (O’Donnell 
et al., 2014). XDR-TB in South Africa is attributed to a high percentage of HIV co-infection, early 
mortality, and inferior treatment outcomes (O’Donnell et al., 2014). Moreover, since HIV-
infected patients are at an elevated risk of acquiring TB infection, the intersection of the human 
immunodeficiency virus-1 (HIV-1) and TB has caused an exceptional double burden of disease in 
the country (Akolo et al., 2010; Meintjes, 2014). Although South Africa encompasses 0.75% of 
the total world population, it is approximated that of all cases of HIV-associated TB that occur 
each year globally, 30% are in South Africa (Meintjes, 2014). 
                                                          
1 A sputum smear is a laboratory test that looks for Mycobacterium tuberculosis in a sputum sample. Sputum is the material that 
comes up from air passages when patients cough deeply (UNDP, 2015). Generally, smear-positive patients with TB are judged to 
be more infectious than smear-negative patients (Hernández-Garduño et al., 2004). 
2 Pulmonary tuberculosis is TB that affects the lungs while the extra-pulmonary is the progression of TB disease which spreads 
from the lungs to locations outside the lungs such as bones, kidneys, etc. (Sreeramareddy et al., 2008). 
17 
 
South Africa's National Response to Tuberculosis 
In South Africa, the National Tuberculosis Control Programme (NTCP) was developed in 1995 
based on the WHO's DOTS strategy (South African National Department of Health, 2008). In the 
South African public health system, TB services, as well as other services, are provided through a 
decentralised model. Based on this model, the National Department of Health regulates overall 
health policy direction while provincial and city departments of health are in charge of service 
delivery through the district health system (Birch et al., 2016).  
In the year 2006, concerning the increasing burden of MDR-TB along with the appearance of XDR-
TB which added further strain to an already overburdened health sector, and with regards to 
address the twofold epidemic of TB and HIV, South Africa established a structured National 
Strategic Plan (NSP) for HIV, TB and STIs (2012-2016). “The targets set in the NSP for TB were to 
halve TB incidence and mortality by 2016 and to have no new TB infections, deaths or stigma by 
2032” (Churchyard et al., 2014, p.244). During 2012-2016 South Africa made remarkable progress 
in enhancing TB control. As an example, there had been a 21% decrease in TB-related mortality, 
from 41 904 deaths in 2013 to 33 063 in 2015, yet the burden of TB remained immense (SANAC, 
2017). Based on mathematical modelling suggestions, besides doing the basics better, scaling up 
ART as well as earlier ART initiation, scaling up use of Xpert MTB/RIF as a substitution for sputum 
smear microscopy, and enhancement of targeted case detection in health care facilities would 
have a considerable impact on TB control (Churchyard et al., 2014; SANAC, 2017). 
The NSP for HIV, TB and STIs (2017-2022) is South Africa's fourth plan. The plan includes eight 
goals, all aligned with a number of objectives as well as sub-objectives (SANAC, 2017). The goals 
set for TB are as follow: 
• 1: Speeding up the preventive services to cut new TB cases 
o Objective: Decreasing the incidence of TB by at a minimum of 30%, from 834 cases 
per 100 000 people (2015) to fewer than 584 cases per 100 000 people by the year 
2022. 
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• 2: Diminishing morbidity as well as mortality of TB through suppling TB treatment as well 
as adherence support for all  
o Objective: Applying the 90-90-90 strategy for TB: detect 90% of all TB cases and 
provide them appropriate therapy; detect at least 90% of the TB cases in key 
populations and put them on appropriate therapy and; successfully cure 90% of 
those diagnosed with DS-TB. 
• 3: Covering all key as well as vulnerable populations through tailored and aimed 
interventions 
• 4: Addressing the social and structural causes of TB  
• 5: Basing the response to TB on the fundamental human rights  
o Objectives: Promoting access to justice for TB-infected patients and other 
individuals who are vulnerable to TB; assisting an environment that preserve 
human rights and hinders stigma as well as discriminations. 
• 6: Enhancing both leadership and shared accountability for an endurable response to TB  
• 7: Mobilizing resources to assist the achievement of the NSP goals  
• 8: Improving strategic information to make progress in achievement of the NSP goals 
o Objectives: Upgrading health information for data utilisation, monitoring and 
evaluating the implementation and outcomes of the NSP; expanding the national 
surveillance system to generate periodic TB measures in the general population 
as well as vulnerable populations; developing strategic researches in order to gain 
approved evidence for innovation and; advancing the efficiency and enhanced 
impact (SANAC, 2017). 
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Literature Review 
Introduction  
TB stands as a major public health challenge in numerous low- and middle-income countries 
(LMICs), inclusive of South Africa. Despite the availability of effective TB treatment and 
therapeutic regimens recommended by WHO (DOTS), treatment success depends on adherence 
to the treatment regimen of daily drugs (Sabaté et al., 2003; Birch et al., 2016). Considering the 
infectious nature of TB as a communicable disease, high level of adherence is necessary to 
decrease the risks of morbidity, mortality along with drug resistance at the individual as well as 
community levels (Sabaté et al., 2003; Birch et al., 2016). The following literature review aims to 
summarise studies from South Africa and similar settings that have analysed adherence to TB 
treatment through a gender lens.  
The Concept of Adherence 
Even though the term adherence has been understood mostly as “medication adherence”, the 
conclusion of the WHO Adherence meeting in 2001 revealed the need for a broader description 
of adherence (Sabaté et al., 2003). Over the past few years, concurrent with a paradigm change 
in patient-provider interaction which is characterized by patient empowerment and autonomy, 
the perception of patient's role has shifted from a “passive, acquiescent recipient of expert 
advice” to “an active collaborator in the treatment process” (Sabaté et al., 2003, p.3; Pulvirenti 
et al., 2014). Consequently, adherence is not only concerned with taking prescribed 
pharmaceuticals but also includes a wide range of health-related behaviours which can 
potentially enhance the patients' health outcomes encompassed with the health care providers' 
recommendations (Sabaté et al., 2003). According to several studies, patient-related factors have 
been frequently cited as the reasons for issues with adherence, while the role of provider and 
health system-related determinants have been broadly neglected. However, Sabaté et al. (2003) 
argues that the patient-provider partnership is a crucial factor in adherence (Sabaté et al., 2003). 
The WHO suggested definition of adherence, “the extent to which a person's behaviour taking 
medication, following a diet, and/or executing lifestyle changes, corresponds with agreed 
recommendations from a health care provider”, gives a high weight on patient's agreement to 
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the recommendations, as active partners with health providers in their health care (Sabaté et al., 
2003, p.3). 
Adherence to Tuberculosis Treatment 
Regarding TB control, adherence can be defined as the extent to which the patient's history of 
remedial drug-taking concurs with the prescribed treatment regimen (Van den Boogaard et al., 
2011). Measurement of adherence to treatment may be either outcome-oriented or process-
oriented. Outcome-oriented approaches use the final results of treatment as an index to measure 
success such as cure rate, while process-oriented indicators use the intermediate variables to 
measure adherence, for example, pill counts. The extent that these intermediate outcomes 
correspond to the actual quantities of prescribed drugs taken is unknown (Sabaté et al., 2003). 
On the other hand, non-adherence may be (1) failure to take any medication; (2) early suspension 
of treatment or (3) aberration from the prescribed treatment in other ways, inclusive of brief 
treatment interruptions as well as miss-dosing (Van den Boogaard et al., 2011). At this point, 
however, there is no empirical definition of non-adherence in TB management and a few 
approaches that have intended to do this have been entangled. To be more accurate, DOTS as 
the standard TB treatment guideline, allows a specific level of flexibility respecting an 
intermittent medication regimen. For instance, treatment can be directly observed by the 
provider either daily or weekly (Sabaté et al., 2003; Munro et al., 2007). Thus, the definition of 
adherence to TB treatment needs to be translated into an empirical method of monitoring both 
the dosage and timing of the medication taken by TB-infected patients. Therefore, the success of 
treatment, here considered as the total number of the individuals who are cured and those who 
have completed therapy under DOTS strategy, can be reasonable, yet a proxy, indicator of 
treatment adherence (Sabaté et al., 2003). 
Factors Affecting Adherence to Tuberculosis Treatment 
Consistent with the view of a majority of studies that inspected adherence to treatment for TB, 
is the point that adherence cannot be defined, controlled, or predicted with a single factor. 
Additionally, according to Hugtenburg et al. (2013), non-adherence with medication is a 
“complex and multidimensional health care problem”, and “the causes of non-adherence may be 
related to the patient, treatment, and/or health care provider” (Hugtenburg et al., 2013, p.675). 
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For each patient, adherence barriers go counter to a number of encouraging factors, and the 
ultimate estimate of patients' adherence relies on which factors prevail. As a result, efforts that 
attempt to boost adherence, treatment results and eventually, to hinder the worldwide epidemic 
of TB, demand a clear insight into barriers as well as facilitators in the context of adherence to 
TB treatment, with specific focus on patient experiences of taking medication (Munro et al., 2007; 
Gebremariam et al., 2010). In terms of TB infection, patients' adherence and the outcomes of 
treatment are tied to regular access to TB services during the treatment course. For the purpose 
of current study, the particular facilitating factors and barriers to the access and adherence to 
treatment for different genders have been classified concerning the three dimensions of access: 
availability , acceptability and affordability (Thiede et al., 2007; McIntyre et al., 2009).  
Acceptability 
Acceptability of TB treatment influences patient adherence in different ways, such as the nature 
of the relationship between patients and health providers, their information on TB and assurance 
of appropriateness of the treatment, social networks, complexity of the regimen and cultural 
belief systems (Sabaté et al., 2003). 
Munro et al. (2007) carried a systematic review to find the critical factors affecting adherence to 
TB treatment through investigating several qualitative researches. Their findings suggested that 
the interaction between patients and providers had a significant influence on the treatment 
adherence of TB patients. Mistreatment and poor follow-up led to non-adherence, notably when 
patients were blamed for the missed visits (Munro et al., 2007). Furthermore, some studies 
reveal that stigma related to TB infection occurs in many health facilities and intensifies problems 
of adherence. In the case of insufficient privacy between caregivers and patients, they refrain 
from collecting medicines as a result of health workers' discriminatory behaviour towards 
patients (Kaona et al., 2004). Therefore, patients were more adherent to treatment when there 
was positive interaction between patients and health care providers (Munro et al., 2007). 
The essence of directly observed therapy is also discussed by Munro et al. (2007), concerning the 
acceptability of treatment. Several researches which were reviewed by the authors revealed the 
patient's negative opinion about direct-observation as well as their distrust of the health care 
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providers (Munro et al., 2007). These are the same findings as those from a South African trial 
which made a comparison between self-supervised TB treatment and DOTS by which the latter 
was seen to have a disheartening effect on TB patients and consequently, adverse consequences 
for adherence, particularly for retreatment patients (Volmink and Garner, 2007). In a similar vein, 
Birch et al. (2016) using a mixed method study, investigated the association between daily 
treatment collection and adherence to TB treatment among South Africans patients. Their 
findings indicated that adherence did not appear to suffer in patients who were not necessitated 
to make daily clinic visits. Moreover, daily clinic visits impose substantial treatment burdens on 
the patients, their families, and on the health care system regarding the human resource 
requirements (Birch et al., 2016). 
In a number of studies, the role of knowledge and beliefs on treatment methods as well as the 
effectiveness of these practices in the health seeking behaviour of TB patients, are taken into 
account. As reported by Munro et al. (2007), some patients will quit treatment as soon as they 
feel better or their signs and symptoms of TB Disease have been relieved or discontinue therapy 
if they see no bettering in their health condition. Based on reviewed studies a probable 
justification for this issue is that patients are not appropriately told about the infectious nature 
of TB, the course of therapy as well as the non-adherence consequences. Moreover, low levels 
of trust in public health services and being in fear of the TB diagnosis may have contributed 
towards patient's uncertainty of the efficacy of the therapy and the validity of the diagnostic tools 
(Munro et al., 2007). 
One of the noticeable acceptability-related hindrance to adherence to TB therapy is the TB-
related stigma (Udwadia and Pinto, 2007). According to a research on adherence to TB treatment 
in a South African community, more than 90% of participants blamed the irresponsible patients 
for spreading the infection, and three-quarters of respondents thought that those who forget to 
take their treatment because they drink and smoke deserve to suffer from the disease (Cramm 
et al., 2010). Furthermore, a number of studies have shown that gender-specific stigma in case 
of TB is an obstacle to women accessing TB care (Onifade et al., 2010). The burden of TB stigma 
falls more on women rather than men. In some communities, a woman who is infected by TB 
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may be divorced or, if she is unmarried, being infected would lead to lower chance of finding a 
husband (Waisbord, 2004; Sen et al., 2007). A study in Vietnam similarly found that isolation, 
ostracism and rejection were results of TB diagnosis for some women who experienced 
remoteness from both family and community (Long et al., 2001). 
Availability  
The availability of TB diagnostic as well as treatment services can influence adherence in various 
ways. A cohort study conducted by Shargie and Lindtjorn (2007) in southern Ethiopia, determined 
the factors that increase the TB treatment non-adherence (Shargie and Lindtjorn, 2007). The 
findings reveal that availability-related barriers that limit physical access to TB facilities, especially 
in rural settings, are among the determinant factors of treatment failure (Shargie and Lindtjorn, 
2007). Based on these findings the distance between the patient's home and health facilities is 
highly associated with adherence to daily-DOTS treatment; about half of the participants who 
failed to complete their TB treatment were living at areas not within reach of a TB facility in less 
than two hours' walk. Moreover, the patient's reliance on public transport diminished their 
chance of completing the treatment (Shargie and Lindtjorn, 2007). Munro et al. (2007) in a 
systematic review about factors related to treatment adherence, also represent same results 
through which absence of available transport and long distances were reported as the primary 
reasons for non-adherence (Munro et al., 2007). 
Regarding TB, the signs and symptoms of the infection are generally severe and exhausting that 
makes it difficult to travel alone. Hence the considerable distances to treatment facilities, as an 
availability barrier, is aggravated by TB symptoms. In a study conducted by Gebremariam et al. 
(2010), majority of patients convey that the burden of travelling long distance in order to get to 
the health facilities extends beyond themselves, since they are in need of their family membersˈ 
accompaniment to get to the facilities which increases the probability of skipping the visit 
(Gebremariam et al., 2010). These results are consistent with the findings of a study conducted 
by Sagbakken et al. (2008) where they observed that health seekers who travelled on their feet 
for about two hours to show up at the TB clinic described the journey as intensely difficult, and 
they experienced frequent fainting and vomiting during travelling. Moreover, these patients also 
reported that as a result of weak management they had to wait for a couple of hours before 
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being visited by a health professional (Sagbakken et al., 2008). Furthermore, long waiting times 
in queues, inconvenient appointment times, and lack of flexibility in operation hours may cause 
high levels of non-adherence to TB treatment as well as loss to follow up (Sabaté et al., 2003; 
Munro et al., 2007). 
Concerning gender-specific availability barriers, some studies have found lack of attention from 
health care providers to women patients who access TB services, which means women must wait 
longer than men to receive the diagnosis as well as treatment (UNDP, 2015). For example, Long 
et al. (1999) in a study conducted in Vietnam, found that as a result of delays caused by health 
care providers, women infected by pulmonary TB were diagnosed approximately two weeks later 
than men (Long et al., 1999). Likewise, a study from Bangladesh revealed that women with TB 
experienced inevitably longer delays to be diagnosed than men (Begum et al., 2001). 
In efforts to enhance the availability of TB treatment through decentralisation and tackling the 
physical barriers to treatment adherence, different systems are provided to assist the delivery of 
pre-packaged doses to the TB patients' home (Macq et al., 2003). Practically, these systems have 
presented their specific barriers. In the case of Pakistan, some assigned community health 
workers (CHW) asked patients to travel to their private residences instead of delivering 
medications to the patient's homes. On the other hand, patients declared that they would prefer 
to conceal their disease due to the fear of stigmatising attitudes within their community against 
TB patients (Khan et al., 2005). Based on a mixed-method analysis conducted by Birch et al. 
(2016), several patients who attended clinics on a daily basis admitted that DOTS with daily 
supervision had imposed a high transportation cost burden on them while most of them were 
already dependent on their relatives or friends to provide them with money to pay for their 
treatment (Birch et al., 2016).    
Affordability 
Even though TB diagnosis and care in South Africa is free at the first point of service, patients 
have to pay considerable costs (direct and indirect) related to TB infection and treatment (Foster 
et al., 2015). So, the affordability-related determinants of access impose an undeniable strain on 
adherence. TB treatment needs frequent service use which generally takes between six and nine 
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months. In the case of any drug resistance or recovery, it might even require more extended 
service use (Cleary et al., 2013). 
In 2008, a qualitative study conducted in Ethiopia analysed the obstacles and facilitating factors 
to TB treatment. This study inferred that the management of TB therapy is the result of a dynamic 
process including the interaction of patients with their community. In such a process, different 
social as well as economic costs interact or change through the years (Sagbakken et al., 2008). 
Moreover, based on their findings loss of employment caused a series of interconnected barriers 
for most of the participants, as those who had insufficient financial resources or lack of support 
from their social networks might find their available resources inadequate to incur total costs of 
attending treatment, which is a barrier to adherence of TB patients (Sagbakken et al., 2008). 
 A similar result was found by Gebremariam et al. (2010), where the authors concluded that DOTS 
was challenging for patients with irregular jobs (Gebremariam, et al., 2010). The time-consuming 
nature of DOTS, as well as severe symptoms of the disease, led a large number of individuals to 
quit their jobs (Sagbakken et al., 2008). By taking Khan et al. (2005) study into account, it is 
concluded that different genders are unequally burdened by time costs whereby work-related 
time costs and family-related time costs impose a higher barrier to men and women, respectively 
(Khan et al., 2005).  
Transportation costs are also a serious barrier to access especially for the patients with financial 
difficulty who need to sell off their belongings to afford transportation costs to TB treatment 
facilities (Gebremariam et al., 2010). Furthermore, based on the findings of a study in rural South 
Africa, transport costs amount to 42% of direct costs for all patients and 51% of direct costs in 
the case of the most deprived quintile. This high direct cost is a barrier for sick and old people 
who are not able to walk several kilometres to get to health facilities (Goudge, Gilson, Steven 
Russell, et al., 2009).  
It is estimated that TB infection causes the adult patients to lose nearly three to four months of 
productivity which leads to a reduction of approximately 30-40% in household income (Udwadia 
and Pinto, 2007). According to the findings of Sagbakken et al. (2008), the majority of 
respondents ranked their employment and income higher than treatment adherence in order of 
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importance (Sagbakken et al., 2008). Other patients who adhered to their treatment through 
visiting the health facilities, because of the loss of revenue, became impoverished and unable to 
afford basic foods and hunger decreased their motivation to continue the treatment (Sagbakken 
et al., 2008). Lack of food was also mentioned as one of the main reasons of interruption of TB 
drug taking in a cross-sectional study in Zambia, where 11.4% of non-compliant patients 
mentioned lack of food at home as the main reason for stoppage of treatment (Kaona et al., 
2004). 
Based on a number of studies, women's lack of financial independence, as well as the low 
prioritisation of women's health by family members, are some common barriers to women 
accessing TB care in various settings. For instance, Onifade et al. (2010) showed that TB care for 
women was of inferior importance to that of men amongst TB control stakeholders (Onifade et 
al., 2010). Moreover, concerning economic inequalities among households, there can be 
significant differences in health gradients between genders so that medical poverty trap may 
impact men and women in different ways and to different extents (Sen et al., 2007).  
As it is discussed, direct and indirect costs are dependent on other dimensions of access: 
availability and acceptability. The social networks have a critical role in a patient's ability to cope 
with the therapy expenses. Despite the high degree of stigma associated with TB infection, 
Sagbakken et al. (2005) noted that during critical situations, many individuals use the shared 
resources from their households or friends to overcome the barrier to access and start or 
continue the treatment. Social support has also been shown to encourage adherence (Sagbakken 
et al., 2008; Gebremariam et al., 2010). Nevertheless, it should be considered that reliance on 
the social networks to cover the expenses of treatment is conditional upon the availability of such 
networks. In the case that social support does not exist, and patients face access barriers, 
untreated infection and premature death will increase. 
Problem Statement 
Tuberculosis is one of the significant public health challenges in South Africa, where TB incidence 
is among the highest in the world. Despite the fact that South Africa made great efforts to address 
the needs of exposed populations, the pace of impacting on the epidemic should be accelerated 
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in order to reach the national and international targets to end the TB pandemic; however, the 
South African health system is dealing with several challenges in this regard (SANAC, 2017). On 
the one hand, the DR-TB is a significant problem to end TB in South Africa given that the number 
of DR-TB cases doubled between 2007 and 2012. Treatment results are unsatisfactory, and 
success rate of treatment is roughly 50% of national and global targets (Cox et al., 2017; SANAC, 
2017). Developing access to culture and drug susceptibility testing (DST) for TB diagnosis may 
help conquer this issue (Dowdy et al., 2008). While most of the present first-line TB drugs were 
developed many years ago, they can have a significant treatment success rate if patients are 
adherent (Shin and Kwon, 2015). Hence, in the light of the infectious nature of TB, for the sake 
of controlling the level and spread of the disease as well as preventing drug resistance, adherence 
to treatment is crucial. Adherence, in turn, will be influenced by the accessibility of needed care. 
On the other hand, barriers and facilitating factors to access and adherence to TB treatment are 
affected by different social determinants of health, inclusive of gender.  
 A number of previous studies have attempted to explain how gender intersects with access 
barriers to TB treatment in various ways. In this regard, several countries reported gender as an 
essential factor in accessing TB services (Kilale et al., 2008). However, findings are frequently 
conflicting in different settings. For instance, Begum et al. (2001) found that females with 
respiratory symptoms had less access to public out-patient clinics compared to males, and were 
less likely to go through sputum smear test in Bangladesh (Begum et al., 2001). On the contrary, 
Iqbal et al. (2011) found that among suspected TB cases in Pakistan, females are two times more 
likely than males to undergo sputum smear test (Iqbal et al., 2011). Based on some other studies, 
males with TB symptoms are more likely to delay seeking treatment for longer than females, and 
male TB patients tend to quit TB treatment as well as to be lost to follow-up, so they are more 
likely to die from TB (van den Hof et al., 2010). 
In South Africa, numerous studies have been done regarding TB infection in various domains. For 
example, Foster et al. (2015) explore the economic burden of TB diagnosis and treatment in South 
Africa. Birch et al. (2016) analysed the relationship between the type of DOTS strategy and 
adherence to TB medication. However, none of the previous studies investigated inequalities in 
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access to TB services by gender in South Africa. This study aims to fill this void through 
investigating gender inequality in access to TB services in South Africa. 
Justification  
TB remains one of the most crucial health challenges globally, causing preventable morbidity and 
mortality, and continues to be one of the serious health threats in South Africa (WHO, 2017b). 
The gender aspects of TB access have been an overlooked research area (Thorson et al., 2007; 
UNDP, 2015). Gender-related access barriers to TB services can impact both men and women. 
Generally, men face a higher risk of developing TB and more TB deaths in comparison with 
women. They are also more vulnerable to TB because of gender-specific occupations (like mining 
or blasting), while women may have inferior access to TB treatment and prevention services than 
men who are more likely to go through sputum smear examinations (The Global Fund, 2017). 
There is a critical need to direct research towards understanding gender-specific barriers to 
access as well as adherence to TB treatment in order to efficiently enable women and men to 
access TB services (UNDP, 2015). Consequently, it follows that evidence-based analysis is crucial 
to quantitatively determine the characteristics of the interaction between gender, access and 
adherence to TB treatment in South Africa. 
Research Question  
The question that frames this study is:  
Do men and women have equitable access to TB services in South Africa? 
Objectives 
This study attempts to address the ensuing objectives: 
1) To describe levels of adherence to TB medication by sex, in South Africa. 
2) To describe differences in access barriers by sex, in South Africa.  
3) To describe the relationship between adherence and access by sex, in South Africa. 
Conceptual Framework 
Equity in health care is frequently defined with regard to access to health services. Access can be 
simply described as the opportunity to use health services while the core of access includes the 
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nature of the interaction between patients and the characteristics of the health system regarding 
delivery and financing. The precise meaning of access is generally unclear (Thiede et al., 2007). 
The overall approach of this study is guided by a comprehensive conceptual framework by which 
access, as a multidimensional concept, is determined through the interaction between the health 
demands of the patients and the acceptability, availability and affordability of the health system 
responses (McIntyre et al., 2009).  
Methods and Analysis 
This section presents a short description of the dataset with further explanation about analytical 
techniques that are used to fulfil the objectives of the study. 
Data Source  
The present study will be based on dataset derived from the Researching Equity in Access to 
Health Care (REACH) project. REACH was a five-year study of health care access in South Africa 
which was launched in 2007. In summary, REACH explores inequity in access to health care 
services across three health interventions (“tracers”): antiretroviral therapy (ART), maternal 
health services and TB treatment services across four health sub-districts in South Africa: Hlabisa 
(KwaZulu-Natal), Bushbuckridge (Mpumalanga), Soweto Region D of the City of Johannesburg 
(Gauteng), and Mitchell's Plain (Western Cape) (Schneider et al., 2012). The REACH project 
sought for a multi-dimensional understanding of 'degree of fit' between health care service users 
and providers concerning availability, affordability and acceptability of health care services 
(Schneider et al., 2012). The author of this protocol had no cooperation in the data collection of 
the REACH study. 
Study Setting  
Four study populations were selected as the sampling frame for this research in different 
provinces, as it is illustrated in Figure 1: two in urban areas (Mitchells Plain, Western Cape and 
Soweto Region D, Gauteng) and two in rural areas (Bushbuckridge, Mpumalanga and Hlabisa, 
KwaZulu-Natal). The logic of this selection was to consider different geographic sites as well as to 
allow for variations in governance context through studying different provinces with extensive 
decision-making autonomy (Schneider et al., 2012). This sampling frame provides the 
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opportunity of comparing the rural-rural, urban-urban and urban-rural differences (Schneider et 
al. , 2012). 
Sampling of TB Service Users and Health Facilities 
Two-stage sampling was used in each of the four sub-districts. The first stage was recruiting a 
representative sample of primary health care facilities, then an adequate sample of users in each 
of these facilities. In most public health facilities in South Africa, TB services are provided. Using 
probability proportional to size (PPS) method, a minimum of five facilities were chosen in each 
sub-district. A random sample of TB patients, in every selected facility, was interviewed until the 
target facility sample size was obtained. The chi-squared ‘goodness of fit’ test was employed to 
calculate the sample size, comparing the socio-economic distribution of need with a hypothetical 
pattern of unequal use based on Bushbuckridge as the example. From this, the planned sample 
size was 1200 respondents, and a minimum of 300 TB patients were interviewed in each sub-
district. Subjects were included if they were older than 18 years old and had been on TB 
treatment for a period of over two months (Schneider et al., 2012). 
 
 
Figure 1. Geographic location of REACH sites (Schneider et al., 2012). 
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Data Collection  
There are two major elements in REACH project field work; first is the interviewer-administered 
exit interview that collected socioeconomic and demographic data, patient's perspectives 
regarding the access-barriers to TB services, self-reported adherence to TB medication, and visits 
to health services or DOTS supporters for TB care; second is the review of patient records. The 
data gathering instruments which are used to collect required data are as follows: (a) exit 
interview questionnaire for TB users (Appendix A); (b) patients record review of TB services 
(Appendix B) (Schneider et al., 2012). 
The data collection process was directed by the previously discussed conceptual framework of 
access through which access is determined with respect to the degree of fit between the health 
demands of the individuals and the acceptability, availability and affordability of the health 
services, as shown in Figure 2 (McIntyre et al., 2009). Based on this framework, the physical 
elements (availability), financial elements (affordability) and cultural elements (acceptability) can 
be probed to evaluate the health care access and the potential barriers of this access. Each of the 
mentioned access dimensions is presentable by a number of variables. 
 
Figure 2. REACH Conceptual Framework (Schneider et al., 2012). 
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Trained interviewers administered a structured exit interview questionnaire in the language of 
patients' preference. Subjects were questioned about the acceptability, availability and 
affordability of TB services through a set of questions that covered particular determinants 
underlying these dimensions (Schneider et al., 2012). The availability is described by variables 
such as patient's travelling time to the facility, the waiting time at the facility for health 
professional visit, the time spent in the clinic to collect medication, the modes of transportation 
to the clinic, and how often they were supposed to fetch their TB drugs from the facility. 
Affordability variables involved coping strategies including whether the patients were forced to 
borrow money to cover the expenses of therapy, as well as information on health care 
expenditure in comparison to the patient's overall household expenditure. Regarding the 
acceptability element, patients were asked about their perceptions of health care providers' 
attitudes, facility cleanliness, waiting time in queues and the stigma of receiving as well as 
treating a TB diagnosis (Cleary et al., 2012). Also with regards to the level of adherence, patients 
were asked about missed clinic visits and missed treatment doses (Birch et al., 2016). 
Furthermore, patientsˈ records were reviewed in order to obtain a more comprehensive 
understanding of the barriers in accessing TB treatment. Moreover, to compare services within 
the facilities with standard treatment guidelines, patient record reviews were undertaken 
(Schneider et al., 2012). 
All interviews were taken with the condition that patients were given the security to disclose 
information; in this regard, a private room at each facility was considered for all interviews, and 
only the interviewer and subject were in attendance. Interviews were conducted after the 
completion of care at that visit and field workers were not a member of staff at the facility. Data 
collection coordinators examined the accuracy of completed questionnaires within each site. 
After approval, responses were entered into a data entry platform which was built in EpiData 
software program (Schneider et al., 2012). 
Data Analysis 
Data were analysed using Stata/IC 15.0. The asset index approach was used to estimate the 
Socioeconomic status (SES) of respondents. Although some argue that SES is best measured by 
household income, consumption or expenditure, these data are generally difficult to collect and 
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are seldom available in developing countries (Montgomery et al., 2000). The asset index 
approach seeks to assign individuals to socioeconomic classes based on household characteristics 
(such as type of house, walls, toilet facility, roof, water supply, electricity for cooking, etc.) and 
assets (including fridge, stove, DVD player, television, cellphone, bicycle, etc.) (Booysen et al., 
2008; Cleary et al., 2012). The index will be constructed by performing a multiple correspondence 
analysis (MCA). While the construction of SES indices is regularly achieved using principal 
components analysis (PCA), this method is more appropriate for normally distributed data, as 
opposed to the predominantly categorical data often used in SES indices development. For these 
reasons, multiple correspondence analysis will be more appropriate (Booysen et al., 2008; Howe 
et al., 2008; Birch et al., 2016). 
In this analysis, we will divide the exit interview template in three analytical scopes, i.e. 
acceptability, affordability as well as availability. The scope of availability will embrace physical 
access aspects inclusive of travelling time to the clinic, the waiting time to visit the health care 
professionals and the mode of travel. The acceptability domain will encompass cultural access 
aspects that involve variables related to structural elements such as facility sanitation, stigma 
and health care staffs' attitudes. The affordability domain will cover financial access aspects like 
if the patient is receiving disability grant or not, the total monthly expenditure on health care 
considering different types of providers, the health expenditure as a percentage of total 
household expenditure, and patient's coping strategy to deal with the costs of health care.  
Adherence to therapy has been defined in various ways in different policy and research contexts 
(Sabaté et al., 2003). For this study, the level of adherence will be measured through a process-
oriented approach by which the intermediate variables of having ever missed a TB clinic visit or 
missed a dose of TB medication will be used as a proxy for non-adherence. 
Summary statistics will be used to compute average scores for each access variable by gender1, 
and multivariate logistic and linear regressions will be used to test for differences in access by 
gender as well as to explore the correlation between gender and patients' level of adherence, 
                                                          
1 In REACH project “sex” is used as a proxy for “gender”. 
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after controlling for socioeconomic characteristics such as asset index, employment status, 
education, and duration on TB treatment. Doing so will allow us to focus expressly on the gender-
level access barriers, after holding other variables constant. 
Limitation of the Study 
A major limitation of the current study is that we are exploring access barriers in a sample of 
patients who have gained entry to the primary health care facilities and are taking TB treatment, 
while impediments to access to TB health services might be different for those who have never 
gotten entry into the TB facilities or patients with severe as well as drug-resistant TB infection 
who need care at secondary care facilities. Furthermore, access barriers are likely to be context 
specific; hence, the findings from this study may not be generalizable to the rest of South Africa 
or other countries. 
Research Ethics 
The present study will be based on a secondary dataset which has already been coded and 
adjusted in order to discard confidential and sensitive information. Nonetheless, before the start 
of the current study, ethics approval has been acquired from the Faculty of Health Sciencesˈ 
Human Research Ethics Committee of the University of Cape Town (Appendix C). Furthermore, 
approval for the REACH project, from which this study is a subset, was provided by Ethics 
committees at the Universities of Cape Town (Appendix D), KwaZulu-Natal and Witwatersrand. 
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Introduction 
This chapter includes a review of the research studies and the literature related to the current 
research objectives. The purpose of this literature review is to set out a theoretical understanding 
about how the acceptability, availability, as well as affordability of health care services, may 
influence the equality of access to treatment, particularly through a gender lens; and to review 
the different methodologies that have been applied in the study of inequality in access to health 
services primarily in the context of LMICs. The chapter initially introduces the South African 
health system and the challenge of equity in this system. Then, the chapter explores the concept 
of equity in health, its importance, and different approaches by which it has been characterised. 
This section further provides a review of access to health care and various approaches to 
determine the association between access to health care services and equity in health. The 
closing part of the chapter explains the comprehensive conceptual framework of access, that has 
been established by Thiede et al. (2007) and McIntyre et al. (2009), with a particular focus on 
gender-disaggregated studies. This framework forms the discussion of several studies that have 
investigated the experienced barriers in accessibility of health care services over three 
dimensions of access. The references which have been cited in this chapter have been derived 
from a number of online databases that are broadly used in health economics studies, such as 
Google Scholar, EBSCOhost, PubMed, and Medline. A set of grey literature inclusive of policy and 
technical reports has also been included in this chapter. These references are adopted from the 
releasing agencies or organisations, including the WHO, Statistics South Africa, and The World 
Bank. 
South African Health Sector and the Challenge of Equity 
According to research-based evidence, the health of a society relies on access to health care, 
which is characterised by the affordability of health care services, the availability of those 
services, and the acceptability of the quality as well as the efficacy of professionals and services 
to the population (Obuaku-Igwe, 2015). Obuaku-Igwe (2015) has highlighted the determinants of 
health inequalities as “…a range of social factors such as; race, education, ethnicity, gender, 
geographical location and income amongst others [while] these factors reflect on and affect 
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other components of a health system, resulting in poor health outcomes, mortalities and financial 
losses” (Obuaku-Igwe, 2015, p.97). 
The health system in South Africa has been transformed since 1994, after the democratisation of 
the country (Van Rensburg, 2014). At that time, the agenda for health policy was developed out 
of the necessity of addressing the highly fragmented health system which existed as the outcome 
of the unjust system during colonialism and apartheid era that principally took responsibility for 
serving the needs of the white minority (Coovadia et al., 2009; Jobson, 2015). Before the 
country's transition to democracy, the health system had been featured with discrimination, 
disempowerment, and underdevelopment while human and financial resources were ill-
distributed, budgets were overspent, and extreme infrastructure disparities were apparent 
between geographic regions (Coovadia et al., 2009). The African National Congress (ANC) and the 
new government made a pledge to improve equity as well as social justice, by establishing the 
ANC National Health Plan and also the White Paper for the Transformation of the Health System 
in South Africa, that later served as the foundation of the National Health Act No.61 of 2003 
(Chetty, 2007). The introduction of the National Health Act reveals that “the socio-economic 
injustices, imbalances and inequities of health services of the past; the need to heal divisions of 
the past and to establish a society based on democratic values, social justice and fundamental 
human rights … [moreover, it states that National Health Act is enacted] in order to establish a 
health system based on decentralised management, principles of equity, efficiency, sound 
governance, internationally recognized standards of research, and a spirit of enquiry and 
advocacy which encourages participation” (Chetty, 2007, p.4). 
Since 1994, the health sector has faced considerable restructuring as well as upgrading in South 
Africa. The fourteen separate health departments of the apartheid era were merged into one 
national along with nine provincial health departments (Wadee et al., 2003; Jobson, 2015). In the 
revised health system arrangement, the National Department of Health (NDoH) set up a new 
health policy framework whereas provincial health departments were tasked with formulating 
their particular policy in the context of the national health framework as well as public health 
service delivery (Coovadia et al., 2009). Primary health care delivery was brought to focus using 
47 
 
the division of health districts as an amalgamated, extensive approach concerning addressing the 
health demands of the citizens, especially those who were underprivileged (Coovadia et al., 
2009). The current South African health care sector consists of a relatively large public sector, a 
fast-growing smaller private sector along with Non-governmental organisation (NGO) providers 
(Jobson, 2015). The health care sector accounts for almost 8.8% of national GDP, with a total 
expenditure of approximately R378 billion during the 2016/17 financial year. Of this total 
amount, about R182.7 billion is estimated to be spent in the public sector which serves more 
than 80% of the population while an estimated R189 billion will be spent in the private sector 
(Veitch, 2017; Fusheini et al., 2018). Despite all the expenditures on health care and 
government's intentions and policy directives, various factors including poverty, high rate of 
unemployment, and the heavy burden of infectious diseases have slowed down the health 
improvements for a high proportion of the population (Fusheini, Eyles and Goudge, 2018). 
Furthermore, in contrary to the government's covenant to enhance the equity in the South 
African health sector since 1994, health disparities have persisted due to the failures of 
stewardship, leadership as well as management, human resource limitations, and incapability in 
providing a health financing system that contains cross-subsidisation based on income (McIntyre, 
2007; Coovadia et al., 2009). 
In accordance with South African health indicators, despite reported progress and 
improvements, not all the health-related MDGs were achieved (Statistics South Africa, 2015). 
South Africa is one of a few countries whose childhood mortality rate and life expectancy have 
worsened since the MDGs were set. Moreover, TB and HIV/AIDS epidemics, mental health 
disorders, maternal and neonatal mortality, and morbidity and mortality resulting from violence 
and injury are other prominent rationales why the country has failed to meet the health 
objectives defined during the time of democratisation (Chopra et al., 2009). This tendency is 
observable in remarkable difference in the rates of mortality as well as the incidence and 
prevalence of diseases between South African racial groups and also between distinct socio-
economic groups; as highlighted by Benatar (2013): “In 2005, infant mortality rates ranged from 
18/1 000 live births among white people to 74/1 000 among black people, which was much the 
same as rates in the early 1990s” (Benatar, 2013, p.154). Moreover, as regards to distributions 
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of cases of HIV and diarrhoea among different socio-economic groups, Ataguba et al. (2011) have 
found that the bottom 40% of the population bears approximately 56% of the burden compared 
to 11% for the top 40% (Ataguba et al., 2011). 
Presently, South Africa is facing a key policy and legislative issue of ensuring UHC through 
National Health Insurance (NHI). This effort is formed on the basis of the democratic right of 
South Africans to have access to quality health care services which are delivered effectively, 
efficiently, equitably, affordably and appropriately according to social agreements as well as 
equity. In this way, health should be viewed as ‘a public good and a social investment’ (Gray and 
Vawda, 2017; National Department of Health, 2017).  
The Public Health Care Sector 
The National Department of Health is directing the public health system and is responsible for 
overall policymaking and coordination while it is predominantly funded through general taxation. 
The application and provision of health services are through the 52 districts and nine provinces 
in South Africa (Coovadia et al., 2009; Massyn et al., 2017). The public health care services consist 
of primary, secondary and tertiary levels through health facilities, which are placed in and 
governed by the provincial departments of health (Coovadia et al., 2009). The primary health 
care clinics, as the basis of the public health system, are the first line of access for patients seeking 
health care services. The services provided by these clinics are free. Access to health care facilities 
has enhanced since the democratisation; yet, in many cases, the quality of health services 
delivered at this level has worsened (Jobson, 2015). District hospitals are the next level of the 
public health care system in South Africa. Health seekers will be referred from primary health 
care clinics once they need further specialised treatments. At the tertiary level, the academic 
hospitals are providing advanced diagnostic procedures as well as treatments. Moreover, these 
hospitals assume the role of training institutions for health care providers (Jobson, 2015). 
Approximately 82% of South Africa's total population, a predicted 45 million people, rely on the 
public health care facilities. However, only 44% of total health care expenditure belongs to this 
sector (Van Rensburg, 2014; Statistics South Africa, 2017b).  
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Since 1994, more than 1600 health care facilities have been modernised or built in South Africa 
(Burger and Christian, 2018). Based on Burger et al. (2012) findings, availability of health services 
has advanced during the post-apartheid era, as the poor report considerably less time travelling 
in order to access health care facilities, which means better physical access (Burger et al., 2012). 
Policies in addressing the affordability barriers in the country have banished the health service 
fees and broadened the priority health programmes for the purpose of improving the 
accessibility of health care, mainly in favour of the vulnerable groups (Van Rensburg, 2014; 
Burger and Christian, 2018). Notwithstanding, a number of recent empirical studies suggest that 
a sole focus on  affordability of health care services will not inevitably advance access to those 
services, as Brink and Koch (2015) and Koch (2017) found no proof that abolition of user fees 
raised the probability of disadvantaged groups accessing public health facilities (Brink and Koch, 
2015; Koch, 2017; Burger and Christian, 2018). Moreover, Goudge et al. (2009) concluded that 
better access to public health care may not be guaranteed only by elimination of user fees and 
that more extensive interventions are required (Goudge et al., 2009). Likewise, Honda et al. 
(2015) argued that betterments in the availability and affordability of public health care services 
in South Africa are not expected to enhance the health results if patients find the quality of the 
services unacceptable (Honda et al., 2015); hence, supposing that public health care services are 
free, perceived poor quality of health care to clients may prevent them from using those services 
(Burger and Christian, 2018).  
In spite of the fact that the post-apartheid government has made exemplary advancement in 
restructuring and enhancing the public health care sector as well as developing access to primary 
care, the health care system continues to be polarised and inequitable (Van Rensburg, 2014), 
predominantly due to shortage of health care workers and disproportionate distribution 
between different sectors and geographical areas (Marten et al., 2014). Furthermore, the lack of 
strong implementation of well-designed health policies developed by the government caused a 
failure in the translation of those policies to the South African population. Hence, with regards 
to addressing the issue of achieving health for all people in the country, enhanced leadership and 
management of policy implementation is required (Coovadia et al., 2009). 
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The Private Health Care Sector 
The private sector covers the health needs of about 16.2% of the South African population, an 
estimated 8.8 million people, by using 56% of the total health care funds existing in South Africa 
(Van Rensburg, 2014; Jobson, 2015). The uneven financing of the private sector, concerning the 
number of beneficiaries, resulted in about eight times greater per capita expenditure in the 
private sector, as compared to the public sector (Fusheini, Eyles and Goudge, 2018). Mainly made 
up of general practitioners and specialist physicians who provide their services on a private basis, 
as well as private hospitals and institutions, the private health care sector is chiefly resourced 
through voluntary medical schemes (covering 83.5% of total private health expenditure) as well 
as out-of-Pocket (OOP) payments (covering 13% of total private health expenditure) (Hassim and 
Heywood, no date; Health Policy Project, 2016). Since there is no financial cross-subsidisation 
between wealthy and poor in health care financing, the fact that affluent people can spend more 
on private health care does not affect public sector financing, and the distribution of benefit is 
still unjustly skewed to the upper-class quintiles who endure the lowest burden of disease 
(Harrison, 2009). The proportion of medical aid beneficiaries has remained practically unchanged 
since 1998, mainly as the result of unaffordability of private medical aid while the OOP 
expenditure for patients seeking treatment through the private health sector has increased 
(Harrison, 2009). The development of the private sector is highly dependent on the growth of the 
real income of the general population, while supplying services for public sector through Public-
Private Interactions (PPls) can be considered as an alternative mechanism for growth (Harrison, 
2009).  
South Africa has about 83 registered medical aid schemes which fund health services for 
approximately 8.8 million members. Due to the regressive financing incidence in the private 
sector, the poorest 20% of medical aid contributors devote twice as much of their income as the 
wealthiest 20% (Harrison, 2009; Health Policy Project, 2016). Moreover, there are 238 private 
hospitals in South Africa, that are unequally distributed across the country, as 188 hospitals are 
located in wealthy urban areas with the greatest supply and only 50 hospitals are located in rural 
areas (Jobson, 2015; Health Policy Project, 2016). The Private sector has been criticised as 
responsible for profound unequal distribution of health workers across South Africa, as nearly 
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70% of medical practitioners are working in the private health care sector (Passchier, 2017). 
These disparities restrain a considerable proportion of South Africans from financial and 
geographical access to health care services, consequently increasing health inequalities and 
threatening the country's efforts with regards to attaining UHC (Fusheini, Eyles and Goudge, 
2018).  
Health Care Financing in South Africa 
In South Africa, health care is funded by means of consolidation of mechanisms (Ataguba and 
Akazili, 2010). Although financing the majority of health expenditure is from the country's 
National Revenue Fund, the country has made strategic use of international aid, mainly in 
assisting its war against HIV (UNICEF, 2017). With regards to revenue collection and contribution 
in the year 2015, 49.8% of total health expenditure (THE) was funded by private resources, 48.3% 
by public resources, and 1.9% by donors. The NDoH and provincial departments account for 2.5% 
and 87% of government health expenditure (GHE), respectively. OOP expenditure at 13.0% and 
medical scheme at 83.5%, account for the majority of private health expenditure (Health Policy 
Project, 2016). Public hospitals charge user fees, differentiated based on income level. In a 
number of medical schemes, beneficiaries were asked to pay co-payments to health care 
providers for certain services which are not included in the benefits package (Health Policy 
Project, 2016). In recent years, the contribution of donor funding to the budget of the NDoH has 
ranged from 2.2% to 3.2%, and has declined to 1.3%, in 2017 fiscal year (UNICEF, 2017). In the 
case of pooling, as it is mentioned previously, the country has 83 private medical aid schemes 
that finance health care services for approximately 16% of the population who are predominantly 
formal sector workers and, occasionally, their dependents. The rest of the population are reliant 
on tax-funded health services, which allows for a large risk pool, enabling people who cannot pay 
for care to receive it (Health Policy Project, 2016). In terms of purchasing, tax-funded services are 
composed of an extensive health package. South Africans have been offered a broad range of 
services, from primary to specialised health care. Private schemes provide key services from the 
prescribed Minimum Benefits Package (MBP). The NHI benefits package has yet to be precisely 
determined, but private medical aids would probably cover additional services which are not 
included in the NHI package. NHI would also organise a transitional fund to purchase primary 
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health care services from certified public and private providers, likewise would eradicate user 
fees in public hospitals (Health Policy Project, 2016). 
Equity in Health  
Over the last few decades, there has been ample recognition of the importance of equity as one 
of the primary goals for health systems and an enormous literature is available on the subject. 
There exists irrefutable evidence on differences in the health profiles of various nations and even 
distinct groups within the same country, mostly rooted in socio-economic disadvantage and 
geographic location (Whitehead, 1991). These differences are made discernible through the 
existence of higher premature mortality rates, lower chances of survival, higher burdens and 
preceding onset of infectious as well as chronic diseases along with accrued disability among 
disadvantaged groups (Whitehead, 1991). Moreover, patients of lower SES evidently consume 
fewer health care services, irrespective of their health demands, and allocate a higher percentage 
of their earnings as OOP payment on seeking therapies which usually drives them into further 
impoverishment. This phenomenon is called the ‘medical poverty trap’ (Whitehead, 1991; Ostlin 
et al., 2005). 
Since the World Health Organisation's Alma-Ata Declaration of 1978 which raised the necessity 
of improving the health of underprivileged groups through primary health care and preventative 
programs, equity has become a primary goal for international public health policy and planning 
(Ong et al., 2009). In 1986, WHO broadened their views and clarified what is meant by health 
equity: “[a situation in which] everyone should have a fair opportunity to attain their full health 
potential and, more pragmatically, that no one should be disadvantaged from achieving this 
potential, if it can be avoided” (WHO, 1986; Whitehead, 1991, p.7). In the same vein, Braveman 
and Gruskin (2003) have described health equity as “… the absence of systematic disparities in 
health (or in the major social determinants of health) between groups with different levels of 
underlying social advantage/disadvantage” (Braveman and Gruskin, 2003, p.254). However, 
there continues to be an ambiguity revolving around the sphere in which the notion of equity is 
defined. Some people consider disparities in the health status of different groups of people while 
others are arguing about injustices in the supply as well as the distribution of health care services 
among a population (Whitehead, 1991). 
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As the most consistent and dominant aspect of all literature, the inequalities which are 
unnecessary, unavoidable, unfair and unjust are the leading cause of health inequity, moreover 
in order to define health differences as inequitable, the causes of these inequalities have to be 
judged unfair, morally and ethically (Whitehead, 1991; Braveman and Gruskin, 2003; Ong et al., 
2009). As it has been mentioned by Whitehead (1991) “Human beings vary in health as they do 
in every other attribute” (Whitehead, 1991, p.6), health differences are only tagged as 
inequitable if individuals have no direct control on their health status due to the circumstances. 
Whitehead (1991) introduced four essential determinants of inequitable health differences: “(1) 
health-damaging behaviour where the degree of choice of lifestyles is severely restricted; (2) 
exposure to unhealthy, stressful living and working conditions; (3) inadequate access to essential 
health and other public services and; (4) natural selection or health-related social mobility 
involving the tendency for sick people to move down the social scale” (Whitehead, 1991, p.5). 
Taking into account all definitions and discussions related to equity, specifically in terms of health 
and health care, this fact is clear that health equity can only be obtained if there is an equal 
chance for individuals to gain health (Whitehead, 1991). This perception reveals the importance 
of access to health care services. Under the circumstances that health care services are the 
solution by which individuals can maintain and enhance their health status, equity in health is 
contingent on equity in access to those services. Oliver and Mossialos (2004) have counted 
significant health equity principles as follow: equal access to health care for equal need; equal 
utilisation of health care for equal need; and equal health outcomes (Oliver and Mossialos, 2004). 
As explained by them, “Equal access for equal need requires conditions whereby those with equal 
needs have equal opportunities to access health care (that is, horizontal equity), and, as a 
corollary, those with unequal needs have appropriately unequal opportunities to access health 
care (that is, vertical equity)” (Oliver and Mossialos, 2004, p.655). Nevertheless, this fact is 
undeniable that individuals with same need and fair opportunities to access health services might 
not make equal use of their opportunities, for instance as a result of different individual 
preferences (Oliver and Mossialos, 2004; McIntyre et al., 2009). Krasnik (1996) also considered 
fair resource allocation as an essential factor to achieve the highest level of health equity, when 
needs-based models are used. Three elements of fair resource allocation are as follow: equity in 
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access, utilisation, and quality of care in respect to health demands, whereby need is defined 
based on the capacity to benefit from care (Whitehead, 1991; Krasnik, 1996; Mooney, 2009). 
Therefore, as a principal foundation to attaining the equity in health care, superior health care 
services should be accessible for all individuals. From this perspective, equity policies related to 
the health sector should be promoted in order to improve access to and control the quality of 
care by checking the following factors: (a) geographical distribution and resource allocation of 
health services in relation to measures of need and access in each area; (b) causes for inadequate 
uptake of essential services by diverse social groups in their efforts to gain access to health 
facilities and; (c) quality of health care along with acceptability as culture-related dimension of 
access (Whitehead, 1991). 
In spite of strong commitment to health equity since 1978, reflected in World Health 
Organisation's Alma Ata Declaration and using a comprehensive primary health care (PHC) model 
which resulted in growth of primary health care enterprises globally, numerous individuals in 
settings with limited resources still do not gain equitable access to primary health services 
(Braveman and Tarimo, 2002; Ong et al., 2009). Primary health care framework did not attain its 
goals for various reasons, inclusive of the refusal of politicians and experts in developed countries 
to accept the truth that each community needs to participate in planning and implementation of 
their health care services. Moreover, affluent nations have been able to follow equity policies 
with fewer efforts in comparison with poorer nations, whose progress in adopting health equity-
related policies has been restricted by appearance and swift growth of communicable diseases, 
shortage of human resources due to globalisation along with poor management and monitoring 
that hampered the health policies from being successfully implemented (Hall and Taylor, 2003; 
Chetty, 2007; Coovadia et al., 2009). The PHC model failure in achieving its equity goals 
concurrent with some shifts in economic philosophy encouraged the substitution of PHC by 
‘Health Sector Reform’ approach. This approach was more focused on delivering health services 
by using private sector rather than governmental services (Hall and Taylor, 2003). Nevertheless, 
macro-economic policies also hindered the health sector reforms from tackling health inequities 
especially in LMICs, as Whitehead et al. (2001) also mentioned, “The actual outcomes of previous 
and current market-oriented reforms have often been contrary to stated objectives, as economic 
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access for poor people has declined, and total costs have increased” (Whitehead et al., 2001, 
p.835; Hall and Taylor, 2003; Gilson et al., 2007). 
Equity in Health Care Services 
Health services, either preventive or treatment, are the mediums through which individuals are 
granted the chance to maintain and improve their health status, and consequently are critical 
components in enhancing the health of the individuals as well as the population (Krasnik, 1996; 
Rosenstock, 1996). Blaxter (1983) has described health care services as a protection against the 
effects of impoverishment, by considering the role of health services with respect to primary 
prevention, curative medicine or secondary prevention, and rehabilitative medicine or tertiary 
prevention (Blaxter, 1983). Mooney (1982) also has presented seven possible definition of equity 
from which two principal perspectives regarding to a clear definition of ‘equitable health services’ 
can be derived: (a) equity in health services is achieved when applicable health-related budget is 
allocated on equal terms amongst geographical areas in accordance with the population's size in 
those areas; further (b) equity in health is fulfilled when there exists equality in the all individuals' 
health status (Mooney, 1982; Whitehead, 1991). There have been many criticisms of these views 
from different perspectives, suchlike in the first case, even if the equitable health care budget 
allocation were achieved, it would not guarantee that different groups with distinct needs for 
health care services are able to meet their needs; moreover, with respect to second view, as 
health care is just one of the numerous factors which contribute to health inequalities in a setting, 
acting in isolation might not be able to necessarily accomplish the desired improvement in entire 
population health status (Whitehead, 1991). 
As defined by Aday et al. (1980), equity in health service distribution will be achieved if ill-health 
is the primary consideration in the allocation of resources (Aday, Andersen and Fleming, 1980). 
They further characterised equitable access to health care services as a circumstances in which 
"services are distributed on the basis of people's need for them” (Aday and Andersen, 1981, p.6). 
Based on this definition, Krasnik (1996) has described an equitable allocation of health services 
as: “… [ a distribution] in which the amount of health care received correlates closely with 
indicators of need and is independent of variables such as income, which are irrelevant to need” 
(Krasnik, 1996, p.3). Krasnik further argued that in order to use such definitions in health services 
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research a number of variables related to the distribution of medical care, need, and other major 
determinants of health should be considered. For instance, the distribution of medical care is 
mostly measured by the amount of utilisation (Krasnik, 1996). With a view to presenting a 
practical definition concentrated on acceptability, quality, and accessibility of the health care 
provided to all sections of the population, equity in health care is redefined by Whitehead (1991), 
as: (a) equal access to available care for equal need; (b) equal utilisation for equal need and; (c) 
equal quality of care for all (Whitehead, 1991). Thereafter, access to and utilisation of health care 
services as two interconnected concepts, have been dominantly involved in health system equity 
research and policy. 
This fact is clear from all works of literature on health and health care equity that equity in health 
can only be obtained if each person has the opportunity to achieve the maximum possible level 
of health. This perception reflects the predominant role of access; if the health services are the 
solution through which individuals and populations can improve their health status, then it 
indubitably follows that equity in health is in reliance on equity in access to health care services 
(Krasnik, 1996). On that account, in order to appropriately discuss the equity in health and health 
care service, a profound understanding of the concept of access is necessary. 
Access to Health Care Services 
In the face of a considerable body of research committed to identifying an applicable concept of 
access, a definition by which accessibility of health care services can be taken beyond the 
theoretical principle remains absent. Shedding light on the ambiguity of the term ‘access to 
health care’, and presenting a commonly accepted definition of that, particularly with regards to 
being operationalised to evaluate health systems in LMICs, was noted as a necessity by several 
studies (Oliver and Mossialos, 2004; McIntyre et al., 2006; Thiede et al., 2007). As highlighted by 
Thiede et al. (2007), “without greater clarity on the concept of access, it is impossible to pursue 
accessible health systems actively”, specifically in contemporary evidence-based policy-making, 
where “…if the access concept is not well understood, comprehensive evidence on what should 
be done to promote equitable health systems cannot be gathered” (Thiede et al., 2007, p.104). 
Moreover, in spite of recurrent reference to ‘equitable access to health care services’ and the 
fact that formulation of the concept of ‘access’ is considerably dependent on the context in which 
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the analysis is taking place, the absence of particular meaning of this notion is problematic for 
governments, leaving them without a reference point for evaluating their health-related policies 
(Goddard and Smith, 2001; Oliver and Mossialos, 2004). Additionally, current debates around the 
concepts of ‘individual empowerment’ as well as ‘informed choice’, which accentuate the 
importance of individual autonomy in decision-making, has expanded the ways by which equity 
and access have been traditionally described (Gulliford, 2009). 
Conventionally, there have been four approaches concerning evaluating access to health care 
services, and each approach has placed different levels of importance on those concerns related 
to supply and those related to demand for health care services. Interpreting access exclusively 
from the supply-side dimension is the first approach in which distribution of health care 
resources to different regions is generally based on a range of specific factors such as population 
size, local input costs, and health care needs (Oliver and Mossialos, 2004). As McIntyre et al. 
(2009, p.182) discussed, from this perspective, access is merely sighted as a matter of location 
primarily measured by provider-to-population ratios while situating a provider in a community 
does not necessarily promise that people are empowered to get the health service they need. 
Hence, this approach wherein the ‘availability of service’ or ‘spatial accessibility’ is used as the 
only proxy for access has been criticised for being essentially simple (McIntyre et al., 2009). 
A second approach through which access to health care is conceptualised has placed greater 
importance on the demand side by referring to patients' ability to pay for health services (Oliver 
and Mossialos, 2004). Within this approach, affordability of health care service is seen as the 
unique proxy for access by which the connection between costs of the services and the patient's 
ability to pay for those services according to their income, insurance coverage as well as eligibility 
criteria for government's health grants were considered (Penchansky and Thomas, 1981; 
McIntyre et al., 2009). Although, as Gulliford et al. (2002) has mentioned, “The impact of user 
charges and other costs of accessing care affect different socio-economic groups in different 
ways. For some groups, access may not be compromised, whereas for others, costs may 
represent a significant deterrent.” As a corollary, same costs do not inevitably provide equal 
access, and the magnitude of the health service costs along with the user's ability and willingness 
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to pay are influential factors on access to health care services (Gulliford et al., 2002). 
Furthermore, monetary incentives to health care providers can impact the availability of health 
care services as well as the quality of those services mainly where providers can choose to offer 
mixed public-private care (Gulliford et al., 2002; Birch and Anderson, 2005). 
In the third approach which has a place in most referenced views of access to health care in 
recent years, access has been indicated in terms of health service utilisation (Penchansky and 
Thomas, 1981; Goddard and Smith, 2001; Ricketts and Goldsmith, 2005; McIntyre et al., 2009). 
Opportunely observed by Donabedian (1972), many individuals who have shared this viewpoint 
trust that "the proof of access is the use of service, not simply the presence of a facility" 
(Donabedian, 1972; Gulliford et al., 2002, p.187). From this angle, use of service is analysed both 
in respect of absolute terms that covers actual use of services as well as the relative terms such 
as different level of health services utilisation across groups with distinct health demands 
(McIntyre et al., 2009). Andersen, Aday and Newman, as pioneers of this approach, formulated 
a framework that has been extremely influential in developing health policies (Donabedian, 1972; 
Andersen and Newman, 1973; Aday and Andersen, 1974; Ricketts and Goldsmith, 2005). 
Although the framework has evolved with the years, this approach substantially relates the 
utilisation of health care services to particular sorts of access, comprised of efficient, realised, 
potential, as well as effective access (Daniels, 1982; Anderson, 1995; Ricketts and Goldsmith, 
2005; McIntyre et al., 2009). Through this framework, Anderson (1995) presents the notion of 
potential accessing to health care services as being utterly reliant on predisposing and facilitating 
elements that are related to the processes as well as the structure of each health system 
(Anderson, 1995; McIntyre et al., 2009). Despite the fact that their framework has been an 
essential foundation for many of the academic essays in terms of recognition and evaluating 
access to health care services, yet its limitations cannot be overlooked. Rendering access as 
service utilisation suggests that an individual who either did not use health care services or used 
different services for the identical health needs had unequal access to health services. However, 
as it has been explained by McIntyre et al. (2009) this statement would only hold true if other 
elements of the relationship between demand and supply, inclusive of health seekers' principal 
health beliefs, values, and attitudes on health as well as health care services were identical 
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(Anderson, 1995; McIntyre et al., 2009). Moreover, as pointed out by Daniels (1982), this method 
is not comprehensively capable of considering equity in access to health services, since “… a focus 
on utilisation rates ignores at least one other necessary condition for equity of access” (Daniels, 
1982, p.60). Their approach does not demonstrate how process variables like OOP health care 
expenditures and waiting time can represent a greater burden to some, especially in the case of 
constant utilisation rates (Daniels, 1982). Furthermore, measuring the ‘utilisation’ may not be an 
appropriate measure of the quality of health care service or there may be alternative therapies 
that are equally effective but not considered, hence the under-utilisation of a unique therapy 
may simply denote use of alternative therapies (Daniels, 1982; Goddard and Smith, 2001). 
A fourth approach has interpreted access as the full cost or shadow price of using a health care 
service. The shadow price includes all costs associated with using services like the cost of 
travelling to visit a physician and waiting time for services besides any price at the point of 
delivery (McIntyre et al., 2009). As Le Grand (1991) argued, the shadow costs of using health 
services should be interpreted as opportunity cost and are highly dependent on the context 
where the cost is carried (Le Grand, 1991; McIntyre et al., 2009). The opportunity cost framework 
has introduced an affordability factor, yet in its broadest term of the available opportunity sets 
to the individual as well as the supply-side effect of cost or shadow price. In this concept, the 
influences of both supply and demand-side are individualised. Furthermore, this framework 
embodies other aspects of access alongside the ones which are broadly taken into account 
through published literature on the conceptualisation of access (McIntyre et al., 2009); as for 
instance, “ensuring that services are available and affordable would not be sufficient to ensure 
access to care if service providers were predominantly male in countries where at least part of 
the population believed it inappropriate for women to be examined by male physicians” 
(McIntyre et al., 2009, p.183). In such circumstances, women as health seeker are incurred by 
opportunity cost in terms of community acceptability and self-esteem coupled with opportunity 
cost related to the shadow price of care (McIntyre et al., 2009). Although a number of authors 
have adopted this framework, complexities in attributing the approach of opportunity cost 
approximation has driven a number of authors to apply the straightforward supply-side estimates 
(McIntyre et al., 2009). 
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As demonstrated by the majority of theoretical literature about the notion of access, the conceit 
itself is composed of a broad range of elements, which are mostly correlated. Furthermore, 
several approaches have been proposed to assess the access to health services, some focusing 
on either supply-side or demand-side, others on both supply- and demand-side. Thiede et al. 
(2007) have developed one of the most recent studies of access, specifically in the context of 
LMICs, which has been further described by McIntyre et al. (2009) (Thiede et al., 2007; McIntyre 
et al., 2009). They have defined access as “the freedom to use health services” (Thiede et al., 
2007, p.105); moreover, they have provided a conceptual framework that describes access as the 
empowerment of an individual to use and benefit from health care services. In this way, regarding 
equitable accessibility to health care services for all citizens, policy-makers are responsible for 
going further than merely ensuring those services are available within a given setting; they are 
supposed to make sure that individuals are empowered to choose and use their required services 
at the time of need (McIntyre et al., 2009). 
According to mentioned framework ‘utilisation of health care’ is not the absolute proxy for equity 
in access, but equitable access to health care can be obtained “…if adequate information on 
health, information on appropriate health care responses and on the opportunities to use health 
services accordingly is effectively communicated across communities” (Thiede et al., 2007, 
p.105). This framework, as illustrated in Figure 1, further presents access to health care as a 
multidimensional concept in accordance with the interplay among the health systems (as supply-
side) and patients (as demand-side). Hence, access to specific health service is led by the ‘degree 
of fit’ among the individuals and the health system across all elements influencing the freedom 
to use health care services (Thiede et al., 2007; McIntyre et al., 2009). Although, the notion of 
‘compatibility’ or ‘degree of fit’ among the individuals and health systems was firstly applied by 
Donabedian (1973) and Penchansky (1977), suggesting that the ‘one size fits all’ description is 
not fitting in health-related policies, it became the basis of access concept in the conceptual 
framework presented by McIntyre et al. (2009) which grants the empirical examination of access 
by classifying factors into three dimensions: affordability, availability, and acceptability (McIntyre 
et al., 2009).  
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Three Dimensions of Access and Implications for Equity 
Each one of the three dimensions of access is distinct and is concerned with a set of particular 
issues: affordability is predominantly focused on features tied to financial access; acceptability 
 
Figure 1. Access evaluation framework (McIntyre et al., 2009). 
is primarily involved in cultural and social-related factors of access and; availability is mostly 
dealing with elements regarding physical access. However, these mentioned dimensions are 
highly interconnected, and access is determined by the interaction between these dimensions 
(Thiede et al., 2007; McIntyre et al., 2009).  
Acceptability 
Acceptability, which mainly assigns to the nature of service provision and the way in which this 
is comprehended by both providers and patients, is the most overlooked dimension of access in 
the empirical literature, yet systematic inequalities in utilisation of health care services have been 
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shown to be moderately associated with acceptability barriers among different settings which 
are evidential of its importance, specifically in terms of discussions on equity-focused health 
policies (Gilson, McIntyre, et al., 2007; Thiede et al., 2007). This dimension, at the 
provider/system level, is mostly focused on the fit between attitudes of health care provider 
towards patient characteristics (such as gender, age, race, language, and SES) and individuals' 
attitudes towards provider characteristics which are under the effect of a number of factors such 
as type of provider, gender, age, race, language, etc. which will affect the nature of patient-
provider interaction and ultimately the patient's ability or freedom to receive care (Thiede et al., 
2007; McIntyre et al., 2009). Furthermore, acceptability at the individual level is concerned with 
a number of factors inclusive of social stigma around diseases, health literacy, and other 
sociocultural features (like gender-related roles and status in the family/community) (Yang et al., 
2014). 
 One of the influential factors with regards to the acceptability of health services is the interaction 
between expectations of providers and individuals and the degree to which both parties respect 
each other's expectations. For instance, providers usually expect the patients to respect their 
professional status and follow their prescribed treatment while patients expect the provider to 
treat them respectfully, undertake a complete examination, explain their disease as well as 
available treatment alternatives. Patients also have other expectations related to health service 
organisations such as efficiency in the process of using services, respecting patients' privacy, and 
avoiding stigmatisation (Thiede et al., 2007; McIntyre et al., 2009). Gilson et al. (2007) have also 
described this dimension as intimately associated with the trust between patient and provider. 
Through this lens, the concept of accessibility includes the fit between ‘lay health beliefs’ and 
‘professional health beliefs’ along with the engagement and dialogue between patients and 
health providers ( Gilson, McIntyre, et al., 2007). 
The Matter of Fit between ‘Professional Health Beliefs’ and ‘Lay Health Beliefs’ 
Lay concepts of illness include individual's perception of their symptoms, disease and appropriate 
treatment alternatives as well as their effectiveness. These beliefs may have emerged from local 
and historical contexts, personal experience and observation, and whether lay publics are 
considering the health and illness about their own or in general (Macintyre, McKay and Ellaway, 
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2006; Gilson, McIntyre and Mooney, 2007). Generally, health care systems, where professional 
health beliefs are mostly rooted from, have been based on the biomedical model of medicine 
which commonly defines disease with consideration of pathology, biochemistry and physiology 
aspects (Gilson, McIntyre and Mooney, 2007). As a corollary of this fact, social determinants of 
disease are much disregarded causing a vast difference in the health beliefs of patients and 
providers. This divergence generated a widespread mistrust between providers and many lay-
populations that has a widely recorded effect on the way that individuals seek medical treatment 
(Gilson, McIntyre and Mooney, 2007). 
In a qualitative study of patient adherence to TB treatment, Munro et al. (2007) conducted a 
systematic review of provider's and patient's visions of adherence to treatment. They found that 
patients refused to accept that they were infected by TB as a result of their distrust in the validity 
of the diagnostic methods as well as the medical system; moreover, some patients refused to 
take medication as they felt it doesn’t do any good for their health (Munro et al., 2007). In most 
cases, this refusal caused poor adherence where treatment was discontinued as soon as 
symptoms had faded. The authors further illustrated that in many instances, TB treatment was 
not even started as a result of false perceptions on side effects of treatment (Munro et al., 2007). 
Patient-provider Dialogue and Engagement  
The quality of communication between patient and provider has considerable potential for 
hindering patients from seeking health care mainly through discrimination, provider attitudes 
towards patients, and issues related to patient privacy that evidently have a terrific effect on the 
level of trust between health providers and patients (Gilson, McIntyre and Mooney, 2007). By its 
very nature, the patient-provider interaction entangles a complicated power dynamic, where 
providers are capable of using their communication practices in order to exercise power over 
patients (Gilson, McIntyre and Mooney, 2007). A vast body of literature has studied the impact 
of such interaction on acceptability dimension of access to TB treatment. 
In a cross-sectional study, conducted by Ibrahim et al. (2014), the provider's knowledge and 
attitudes towards TB patients under the DOTs treatment in Nigeria has been investigated. Based 
on their findings, lack of awareness of the health care workers on the management of TB patients 
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and poor interpersonal interaction with patients have an adverse effect on patients adherence 
to TB treatment (Ibrahim et al., 2014). In a similar strain, Noé et al. (2017) have conducted a 
descriptive, cross-sectional study by using a specifically designed Knowledge, Attitudes and 
Practices (KAP) questionnaire in the district of Manhiça which is a high TB burden rural area in 
Southern Mozambique (Noé et al., 2017). Their findings indicated that more than seventy per 
cent of respondents had never heard of Xpert MTB/RIF as a TB diagnostic test. Moreover, less 
than fifty per cent of respondents correctly approved that paediatric TB was more challenging to 
diagnose compare to adult TB and less than twenty-five per cent of respondents accurately 
determined the dissimilarity of required treatment time between adults and children. About 70% 
of participants admitted that there was a stigma associated with TB from which about 48% 
agreed that this stigma was greater than HIV-associated Stigma (Noé et al., 2017). The authors 
concluded that the provider's knowledge gaps and their stigmatising behaviour disclosed in this 
study might induce inferior patient care (Noé et al., 2017). 
Considering previous discussions around the beliefs of health professionals and lay public about 
different aspects of health in addition to the level of engagement and dialogue between them, it 
is an undeniable fact that good information promotes the ‘fit’ between individuals and the health 
system (McIntyre et al., 2009). In a general sense, imbalance of information generates power 
relationships unequally distributed between patients and providers which can dramatically 
influence each access dimension, for instance, providers' eagerness to involve the patient in 
making treatment decisions can highly affect the acceptability of health service (McIntyre et al., 
2009). Acquiring an acceptable level of health literacy and consequently being well-informed, is 
the result of effective communication between patients and providers which is directly linked to 
health outcomes (Thiede et al., 2007; Batterham et al., 2016). In terms of acceptability dimension 
of access, information of patients' rights can direct their expectations of providers and the extent 
to which providers respond to these expectations. Moreover, providers' awareness of cultural 
beliefs in the local community may help them to adapt services appropriately and improve the 
acceptability of service (Thiede et al., 2007; McIntyre et al., 2009).  
65 
 
Health Literacy and Stigma 
The association between low literacy skills and health status has engendered the emergence of 
the concept of health literacy, although the definition of this concept has continually evolved in 
recent years (Nutbeam, 2008; Easton, Entwistle and Williams, 2013). Zarcadoolas et al. (2005) 
defined health literacy as “the wide range of skills and competencies that people develop to seek 
out, comprehend, evaluate and use health information and concepts to make informed choices, 
reduce health risks and increase quality of life” (Zarcadoolas et al., 2005, p.196). Moreover, 
health literacy which provides individuals with knowledge and confidence to access, use and 
navigate health and social care information and services, has a principal role in control of any 
disease and is highly related to the health outcomes (Easton, Entwistle and Williams, 2013; 
Roberts, 2015; Daftary et al., 2017). In the causal pathway between health literacy and health 
outcomes, mediators are the factors that explain all or part of the correlation. Level of patient 
self-efficacy, knowledge, value and norms, disease-related as well as poor literacy-related Stigma 
are among those factors that can mediate the (direction or magnitude of) association between 
health literacy and some health outcomes, such as adherence to treatment (Berkman and 
Donahue, 2011).  
In a qualitative study conducted by Easton et al. (2013) the effect of low-literacy-related stigma 
on patient-professional verbal interactions and health outcomes were investigated (Easton, 
Entwistle and Williams, 2013). According to their findings, the stigma of low literacy had a 
significant adverse impact on patient-provider verbal interactions. Several communication 
difficulties were worsened since participants limited their dialogue with health care professionals 
and used different approaches to hide their poor literacy that could send false signals to 
providers. In conclusion, they highlighted the fact that low-literacy-related stigma can severely 
weaken patient-provider interaction and patients' potential to benefit from health services 
(Easton, Entwistle and Williams, 2013). 
At the individual level of acceptability, mostly in terms of social stigma around TB infection, there 
exists an extensive literature, including gender-disaggregated analyses. In a systematic review of 
qualitative studies, Krishnan et al. (2014) have explored gender-related barriers and delays in 
accessing TB Services (Krishnan et al., 2014). Their findings affirmed that TB-related stigma, which 
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is highly overlapping with limited health literacy, is a principal barrier to accessing TB services in 
most settings. This stigma extensively affects both genders, with women expecting greater 
stigma with family members and lack of proper care from them whereas men dealing with more 
workplace as well as community stigma. Furthermore, women reported higher psychosocial 
corollaries of TB stigma such as feelings of isolation, fear of divorce or compromised marriage 
prospects, in case of being unmarried, and were more likely to conceal their TB status or delay 
seeking treatment as a result of stigma (Krishnan et al., 2014). Likewise, Onifade et al. (2010) in 
their qualitative study on gender-related factors influencing TB control in Shantytowns found 
that women reported feeling the burden of TB-related stigma more intensely than men. Hence, 
most tried to hide their diagnosis due to fear of rejection as well as isolation, and a number of 
other women mentioned they had been discriminated against because of their diagnosis while 
men were indifferent about the opinion of others (Onifade et al., 2010). 
Considering all the above discussions on acceptability dimension of access, this fact is clear that 
ensuring the individual's empowerment to use health care services is a critical factor in achieving 
public health goals particularly those that rely on treatment adherence. Acceptability barriers 
generally emerge in a situation that health care services are organised from the perspective of 
the system and its providers, instead of the perspective of patients (McIntyre et al., 2009). 
Affordability  
The affordability dimension of access, have recently dominated the debate around equity in 
health care, especially for populations living within LMICs. The concept of affordability represents 
an individual's financial access to health services by examining the goodness of fit between the 
full costs of seeking care to the patients using the health services and their ability-to-pay for these 
services, generally reflected by their SES (McIntyre et al., 2006; Thiede et al., 2007). This 
dimension further explores the potential effect on household well-being of spending the 
household budget to pay the expenses of health care services (McIntyre et al., 2009). McIntyre 
et al. (2006) has presented a diagram in order to illustrate key subjects in the emerging 
experience of the economic consequences of ill-health and using health services (outlined in 
Figure 2), particularly within the context of LMICs, that generally fall into two main categories, 
videlicet, direct and indirect costs (McIntyre et al., 2006; Thiede et al., 2007). 
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Figure 2. Clarified diagram of essential issues connecting to the economic consequences of ill health (McIntyre et 
al., 2006). 
 
Direct and Indirect Costs of Illness  
Regarding measuring the economic cost of illness (COI) and evaluating the affordability of health 
service in the public health field, two various indicators have constantly been used: (a) health 
care expenditure as a proportion of total household income, also known as direct cost burden; 
(b) production and income loss due to illness as a proportion of ‘normal’ income, also known as 
indirect cost burden (Russell, 2005; Jo, 2014).  
Being borne by patients, their family and ultimately health systems, the direct cost of illness 
refers to the range of health care and non-health care costs. The former typically includes official 
consultation fees (OOP payment or co-payment in case of being insured); unofficial or ‘under-
the-counter’ payments; cost attached to diagnostic tests as well as medicine charges and; fees 
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attached to hospitalization suchlike pre-admission payments, ward and theatre costs; while the 
latter is the costs of non-health items which require direct payment inclusive of transportation, 
particular food or special dietary requirements following treatment as well as child-care costs 
when seeking health care (Thiede et al., 2007; McIntyre et al., 2009; Jo, 2014). On the other hand, 
indirect cost of illness, which is also known as ‘productivity cost’, typically includes productive 
time losses and lost income to the person who is ill, their household and even their employer 
while travelling to receiving care or waiting to be visited by a health professional (McIntyre et al., 
2006; McIntyre et al., 2009; Jo, 2014).  
Generally, indirect costs are more inconsistent to measure in comparison to direct costs (Russell, 
2005; Jo, 2014). In terms of direct costs, one of the significant diversities between researches is 
the recall period applied in the household surveys which can be either one or two week. 
Additionally, the other difference between studies is that some analyses exclusively focus on 
direct expenses concerned the health care service while others also include non-health care 
direct costs like transportation fees (McIntyre et al., 2006). In case of measuring indirect costs, 
some studies measure only the number of days off work due to ill-health, mostly include 
additional morbidity time while a few also estimate total years of productive life lost due to the 
early death to consider lifetime income foregone. Additional challenges arise through the various 
methods by which these estimates are rendered into monetary values, such as whether actual 
income lost or average wage rates are applied to productive time losses; in what way studies 
quantify cost of time lost for individuals who are not employed in the formal sector and; how to 
calculate the cost of time lost with regards to total unpaid household activities (Chima, Goodman 
and Mills, 2003; McIntyre et al., 2006; Jo, 2014). Another entangling element is that the data may 
be displayed in various formats, for instance, costs as a percentage of monthly household income 
or as a percentage of annual household income (McIntyre et al., 2006). 
With reference to the vast body of research on financial barriers in access to TB services, this fact 
is clear that the cost burden of obtaining TB care and the following treatment is a broad subject 
affecting both genders, although in a slightly different way (Krishnan et al., 2014). In a study 
conducted by Liefooghe et al. (1995) on social consequences of tuberculosis in Pakistan, the 
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results revealed that men were more likely to experience the direct and indirect economic 
consequence of illness, since their role as wage-earner would be restricted due to the disease, 
while married women were faced with a different financial burden. As the result of their marriage 
they belonged rather to the family-in-law than to their own family and they mostly lacked 
financial independence hence were reliant on their husband's financial support for their 
treatment while in-laws did not seem to feel the same responsibility for them as their own 
families did (Liefooghe et al., 1995). 
Coping Strategies and Ability-to-pay  
With respect to estimating the burden of disease, morbidity and mortality have been focused as 
two key indicators of a population's health-level, yet the negative impact of poor health on 
individual's well-being should be explored through a broader lens. To illustrate, unpredicted 
increase in health expenditure along with lowered functional capacity and lost earning or 
productivity, which are also known as ‘health shocks’, are among dominant risk factors for 
underdevelopment (World Health Organization, 2009). In a conceptual framework presented by 
Russel (2004), household has been considered as the preferable unit of analysis for measuring 
the costs of illness since final decisions about treatment are based on negotiations within the 
household, both caregivers and the patient bear ill-health costs, and ultimately costs fall on the 
household resources (Russell, 2004). Hence, at the microeconomic level, households who face 
health shocks usually employ various ‘coping strategies’ to alleviate the financial burden of 
illness, however there is a debate on the effectiveness of these coping mechanisms regarding 
longer-term asset and livelihood preservation; moreover, coping strategies are not free of cost 
and may impose harmful consequences on households in the future (Leive and Xu, 2008; WHO, 
2009). As Russel (1996) argued, if households have to sacrifice some basic needs including food 
and education in order to pay the costs of treatment, the opportunity costs related to treatment 
might make it ‘unaffordable’ since other essential needs will be sacrificed (Russell, 1996). It is 
generally held that a total cost of illness exceeding 10% of household income is expected to be 
catastrophic and may put the household at the risk of impoverishment, yet considering different 
socio-economic statuses, it may not be true for affluent households that can promptly mobilize 
cash to pay the cost of treatment or even in the case of poorer households that a lower 
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proportion may be catastrophic (Russell, 2004; McIntyre et al., 2006). This issue accentuates the 
necessity of considering the notion of ability-to-pay concerning the individual as well as 
household's income level by considering other demands on that household's resources (Cleary 
et al., 2013). 
The ability-to-pay as one of the key components of affordability dimension is affected by a 
number of factors. On the one hand, the eligibility of health seekers to benefit from different 
financial supporting mechanisms (such as public funding and health insurance) that protect them 
against the burden of health care costs at the time of service use may be influential. Moreover, 
the ability of households to cover the costs of health services at the point of delivery can also 
impress the individual's ability-to-pay in different ways, inclusive of the amount as well as 
schedule of income payments along with the individual's ability to make use of that income flow; 
the amount of cash savings and other assets owned by the household from which households 
can mobilize cash to cover the health care costs; the level of confidence in social networks in 
order to ask for financial assistance as gifts or loans and; the individual's capability to face indirect 
costs such as protecting income through sick leave benefits or replacing workforce to protect 
productivity in case of self-employment. In this vein, two individuals may have to meet the same 
costs of care which they both have the ability to incur; however, the consequences for the rest 
of their lives and that of their households may be dissimilar (Thiede et al., 2007; McIntyre et al., 
2009).  
With respect to financial barriers in access to TB services, a series of studies have indicated the 
inequitable allocation of household resources as one of the causes for gender-related inequity in 
access to TB health care services whereby men, as well as children, receive a larger proportion of 
total household resources. Mostly, men's well-being, as the primary breadwinner, is prioritised 
by households while women's health is undervalued due to inferior status within households and 
lack of financial autonomy (Krishnan et al., 2014). In their investigation on access and adherence 
to TB treatment in Burkina Faso, Sanou et al. (2004) concluded that mobilising cash for covering 
the costs of daily accessing to the health care centres was difficult, mainly for women. Through 
an in depth-interview conducted in their study, one of the female TB patients claimed: “I don’t 
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have any financial means, I have to bow to the decision of my brother-in-law” (Sanou et al., 2004, 
p.1481). 
Ill-health and Poverty 
As implicated in the discussion above, the economic costs of illness and consequently applied 
coping mechanisms differ among households with distinct socio-economic status. Looking across 
the vast body of existing literature, this is evident in the fact that the catastrophic health care 
expenses and that low-quality services hinder health service utilisation, particularly among the 
underprivileged; hence health services are mostly impotent in reaching the poor and generate 
less benefit for the impoverished than the better-off households. Moreover, health care services 
may create regressive cost burdens, as poor households spend a higher proportion of their 
income on health care than affluent households. In this context, a health care financing 
mechanism will be progressive as well as fair, if health care expenditure is moderately low in 
poorer households, yet this only holds true to those who can afford to access and use health 
services (Russell, 2004; McIntyre et al., 2006). Whitehead et al. (2001) have defined a 
phenomenon in which “…rises in out-of-pocket costs for public and private health-care services 
are driving many families into poverty, and are increasing the poverty of those who are already 
poor”, as ‘medical poverty trap’ (Whitehead et al., 2001). The medical poverty trap dictates a 
number of effects, such as untreated illness, lower access to care, enduring impoverishment, and 
irrational use of medicines (Whitehead et al., 2001). In the case of untreated morbidity, as the 
most severe consequence of the medical poverty trap, those who cannot afford the health care 
services and hence ignore their illness, are at risk of further suffering and worsening health. In 
the same context, irrational prescribing of drugs by whom either has financial incentives to 
overprescribe or are not qualified is another significant contribution to the inequities of the 
medical poverty trap. As a corollary to this phenomenon which is most common in developing 
countries, poor people may receive ineffective or even hazardous treatment, such as 
inappropriate TB treatment which in fact increase the risk of drug resistance (Whitehead et al., 
2001).  
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Availability  
The availability dimension, which investigates the importance of physical access (spatial access) 
to health care services, is involved in whether or not the relevant health care professionals and 
services are provided at the appropriate time and in the proper place that they are needed to 
meet the population's health demands (Thiede et al., 2007; McIntyre et al., 2009). In order to 
describe the availability, the fit among individual factors and health system elements should be 
explored. Individual factors influencing availability dimension are as follows: the health needs of 
individuals as well as the severity of their condition; the patients' locations and their means of 
transport and; the time that individuals need services to be provided. The health system 
elements are inclusive of the location of health facility; level of supply of staff or drugs; the 
organisation and qualification of personnel as well as their willingness to serve the patients; the 
appointment system; the facility hours as well as working hours of health professionals and; the 
form of services that they provide (inclusive of quantity, quality, whether they provide in-patient 
care or out-patient care, and whether they provide comprehensive care or patients will be 
referred to different facilities in multiple locations) (Thiede et al., 2007; McIntyre et al., 2009). 
In 2009, Goudge et al. (2009) conducted a longitudinal case study to explore barriers to accessing 
chronic disease treatments in South African context (Goudge et al., 2009). Their findings on 
availability dimension illustrate that due to health system deficiency as well as unavailability of 
required services for chronic care, provided services did not result in regular treatment and 
control of symptoms. A number of respondents mentioned interrupted drug supply by clinics as 
one of the major barriers that led them to self-treatment rather than wasting resources on 
transport for an ineffective trip to their local clinics that frequently ran out of drugs. Moreover, 
as a result of poor clinical services and weaknesses in diagnosing and treatment prescription at 
clinics, some participants were asked to return to the clinic in two weeks to collect the TB-test 
results that cost them transportation fee and delayed their treatment. Other barriers highlighted 
by participants were weaknesses in the referral system and insufficient ambulance services. In 
one case, different diagnoses by the clinic and the hospital and their failure of communication, 
left the patient confused about whether she should go to the clinic or hospital for further 
treatment. The authors conclude that in order to enhance the public sector it is crucial to 
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improving public clinic's capacity, referral systems, ambulance services, and drug supply chains 
besides addressing the financial barriers faced by the socially deprived patients (Goudge et al., 
2009). 
In a similar vein, Burger and Christian (2018) have combined the data of South Africa's 2009 and 
2010 General Household Surveys with quantitative methods to investigate the barriers to 
accessing health care services in South Africa during the post-apartheid era (Burger and Christian, 
2018). According to their findings, high levels of acceptability but lower levels of affordability as 
well as availability of health care services, particularly for vulnerable groups such as the poor, 
black South Africans, and the rural population were existing. The most substantial constraints in 
access were in the availability dimension (including distances, transport costs, and improper 
opening times) where 27% of individuals were reported as facing barriers. A high inequality in 
availability among the poor (59%) and the non-poor (83%) was observed. Moreover, urban 
residents (85%) reported higher unavailability in comparison to rural residents (60%) (Burger and 
Christian, 2018). 
In 2008, through a gender-disaggregated study, Mfinanga et al. (2008) have explored the 
significance and elements of the postponement in the management of smear-positive TB in Dar 
es Salaam, Tanzania (Mfinanga et al., 2008). A cross-sectional hospital-based survey was 
distributed to three districts of Dar es Salaam that has the most substantial burden of TB patients 
in Tanzania. In their study referral delay was applicable when the time between the first visit to 
a doctor and the time the patient is seen at a health facility with DOTS services exceeded 48 
hours. Also, diagnosis delayed was defined as a situation in which the time between the first 
consultation at a health facility providing DOTS services and diagnosis of TB exceeded 72 hours 
(Mfinanga et al., 2008). Their findings illustrated that 52.9% of the patients experienced 
postponement in diagnosis. Delayed TB diagnosis was more common in females (62.1%) than in 
males (47.0%). Moreover, facility delay which was reported by more than four-fifths of the 
participants was significantly higher in females (88.8%) than in males (79.8%). These results 
revealed that female participants in the study experienced greater availability barriers than the 
male participant (Mfinanga et al., 2008). 
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Considering all the preceding discussions on the availability dimension of access, the impact of 
availability dimension on the patient's empowerment to make use of health services can be 
evaluated only if interactions among different factors influencing this dimension are recognised. 
For instance, as mentioned by McIntyre et al. (2009), “Trade-offs may exist between geographic 
distance to facilities and the quality of care provided” (McIntyre et al., 2009, p.185). 
Conclusion 
As highlighted in the presented literature review, the South African government is facing the 
challenge of diminishing imbalances of health services of the pre-apartheid era and establishing 
a society based on social justice and basic human rights. In South Africa, just like most of the 
other countries in the world, the rate of disease and mortality are indeed higher among the 
marginalised population. Inequitable barriers exist in accessing health care services are among 
the biggest and most avoidable causes of health disparities in every context. A number of 
previous studies in various contexts have attempted to investigate if gender intersects with 
access barriers to TB treatment. Evidence suggests that several countries reported gender as an 
important factor in accessing TB services; however, there was no specific study on this topic in 
the South African context. The present study aimed to explore the gender-related disparities in 
accessing TB services in South Africa, through a gender-disaggregated analysis by applying 
comprehensive conceptual framework of mapping access to health care services which is 
developed by Thiede et al. (2007) and McIntyre et al. (2009). Based on the above literature, the 
mentioned conceptual framework describes access as the empowerment of an individual, 
specifically within the context of LMICs, to use and benefit from health care. This framework also 
grants the empirical examination of access by classifying factors into three dimensions: 
affordability, availability, and acceptability through focusing on both supply- and demand-side 
factors.  
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Objective: As one of the major public health challenges in South Africa, it is crucial 
that increased attention be paid to controlling the TB epidemic. While gender, as a 
social determinant of health, has been reported to impact the access and adherence 
to TB services in other settings, gender-related barriers to TB access have been an 
under-researched area in South Africa. This paper explores gender-based disparities 
in access and adherence to TB services in South Africa, from the perspective of TB 
patients attending primary health care facilities. 
Methods: Using a comprehensive framework of access, interviews were conducted 
with 1229 TB patients from four health sub-districts in South Africa, to assess 
gender-related inequalities across the access dimensions of availability, affordability 
and acceptability of TB services. Descriptive statistics were computed, and 
comparisons of access barriers and adherence between men and women were 
explored using multivariate linear and logistic regressions. 
Results: There was no significant association between levels of adherence and 
gender (all p-values> 0.05). Among availability-related variables, men spent 
significantly less time at the clinic to fetch TB medication (coefficient, -7.06; 95% 
CI, [-13.5, -0.7]); however among affordability-related variables, men were 
significantly less likely to receive a disability grant (AOR, 0.48; 95% CI, [0.36, 
0.63]), and among acceptability-related variables men were significantly less likely 
to judge the length of queues to be too long or the cleanliness of the facility to be 
sub-standard (AOR, 0.69; 95% CI, [0.52, 0.91], and AOR, 0.67; 95% CI, [0.46, 
0.97], respectively). 
Conclusions: Our findings indicate that there is no association between the level of 
adherence to TB treatment and gender. Moreover, there was no evidence of 
systematic gender-based inequalities in access to TB services. However, the findings 
reveal concerns about the condition and cleanliness of health facilities that may 
impact the patients' adherence and be a barrier, specifically, in women's use of TB 
services.  
 
 
Introduction 
Tuberculosis (TB), as a major public health challenge, 
encompasses a high proportion of the global disease 
burden and is associated with significant gender-
related inequalities, described by binary male/female 
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sex categories [1]. TB is the leading natural cause of 
mortality in South Africa, and the country has the 
sixth-highest TB burden globally [2,3]. In 2016, there 
were an estimated 438 000 new diagnoses, at a rate of 
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781 cases per 100 000 population, from which 182 000 
cases were among women and 256 000 were among 
men. South Africa also has the highest burden of HIV 
co-infected cases in the world, estimated at 258 000 
[4]. The emergence of multidrug-resistant tuberculosis 
(MDR-TB) has been the main contributor to the high 
burden of TB in the country wherein treatment 
outcomes are poor, with a success rate of 
approximately 50% [5]. Globally, the majority of 
reported cases of extremely drug-resistant TB (XDR-
TB) are from South Africa. XDR-TB is the most drug-
resistant form of TB which is expensive and difficult 
to treat as well as associated with high mortality rates 
and treatment failures [6]. Moreover, since HIV-
infected individuals are at higher risk of developing 
active TB, the intersection of TB and HIV has caused 
a double burden of disease in the country [7,8]. 
In 1996, the outbreak of MDR-TB in South Africa was 
declared a national emergency; consequently, the 
South African government developed the National 
Tuberculosis Control Programme (NTCP) on the basis 
of the Directly Observed Treatment, Short-Course 
(DOTS) strategy which had been introduced by the 
World Health Organization (WHO) to improve patient 
adherence [9-11]. In spite of considerable 
achievements, the case detection and treatment 
success rates remained less than 60% and 76%, 
respectively, falling short of the WHO targets of 70% 
case detection and 85% treatment success rates [12]. 
In 2011, the government revised the guidelines 
supporting decentralised DR-TB service provision and 
also implemented new diagnostic tests such as the 
Xpert test. These responses increased the number of 
diagnosed DR-TB cases, and South Africa has made 
considerable progress in enhancing TB control since 
2012 [9,13]. Indeed, TB-related mortality decreased 
by 21%, from 41 904 deaths in 2013 to 33 063 in 2015; 
however, the current rate of decrease is too slow to 
meet the 2030 Sustainable Development Goals 
(SDGs) as well as 2035 End TB Strategy targets [4]. 
Inferring from WHO estimates, tuberculosis incidence 
rates for South Africa would need to decrease to less 
than 167 cases per 100 000 population, and mortality 
also would need to reduce to 9800 in order to meet 
these targets [13].  
Over the past two decades, the focus of the NTCP has 
been on improving the rates of treatment success while 
failing to address upstream losses experienced by 
patients who did not gain access to health services and 
whose infections were not diagnosed and treated [13]. 
Therefore, to reach the SDGs and end the TB epidemic 
in the country, a comprehensive understanding of 
access barriers to TB services is necessary, including 
an understanding of how these barriers intersect with 
gender [1,4].  
Broadly, improving access to health care is a crucial 
goal of universal health systems; yet, there still exists 
controversy over the precise meaning of the term 
access to health care [14,15]. In the earlier literature, 
access to health care was primarily regarded in terms 
of two key factors: distance travelled to use health care 
services as well as money fees at the point of service 
utilisation. Others have proxied access as service 
utilisation, which is easier to measure and evaluate. 
Recently, access has been defined as the 
empowerment of a health seeker to use health care, a 
multidimensional concept based on the degree of fit 
between individuals, households, communities, and 
health care systems. According to this 
conceptualisation, the three dimensions of access are 
affordability (or financial access), availability (or 
spatial access), and acceptability (or sociocultural 
access) [14,16]. The three dimensions of access are 
argued to be a starting point for empirical investigation 
of access to health services and also for health policy 
development, that can address detected barriers [16]. 
The present study aims to unpack the gender-related 
barriers and inequalities in access to TB treatment 
services in South Africa. Findings from this study may 
provide evidence to assist in evaluating the success of 
the current TB policy and may further assist in 
designing policies to improve health equity between 
men and women as well as ensuring that the TB-
related goals set by the WHO will be achieved. 
Materials and methods 
Study Design & Conceptual Framework of Access  
This study relies on data drawn from the Researching 
Equity in Access to Health Care (REACH) project, a 
study of health system access in South Africa 
conducted between May 2007 and April 2012. Full 
details regarding data collection can be obtained from 
published sources [17]. In summary, an interviewer-
administered, exit interview-style questionnaire was 
developed to gather socioeconomic and demographic 
data; data regarding the individual's housing 
characteristics; an estimate of household income, 
monthly household expenditure, and household assets; 
as well as data concerning key barriers to TB treatment 
accessibility, from the patients' perspective. 
This study is framed within a conceptual framework of 
access where access is defined in terms of the degree 
of fit between the needs of individuals and health 
system responses within the dimensions of 
affordability, availability, and acceptability. A 
fundamental part of this framework is the 
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understanding that while each dimension of access is 
focused on its issues, they are interconnected and 
impact the interaction between the health system and 
its users. More precisely, affordability is principally 
concerned with the degree of fit between costs of 
service use and household ability to pay; availability 
is affected by the fit between population needs and the 
type, place and time of services provided; and 
acceptability is focused on the degree of fit between 
provider and patient expectations of and attitudes 
towards each other [14,16]. In accordance with 
Braveman & Gruskin [18], inequalities in access 
emerge if barriers are systematically different for 
individuals with distinct levels of social advantage, 
including with respect to their gender. As an example, 
if reported TB-related stigma is higher among female 
participants as compared with males while females 
may delay or reject seeking treatment as the 
consequence of stigma burden, then this is evidence of 
gender inequalities in access to TB services. 
In this study, each dimension of access is captured by 
several variables. Availability variables incorporate 
the travel time to reach the TB treatment facility, the 
mode of travel and the waiting time at the facility for 
health professional visit during the previous clinic 
attendance. Affordability variables included whether 
or not the participant was receiving a government 
chronic care grant, and the cost incurred during the 
current TB facility visit which was converted to 
monthly expenditure estimates using information on 
the reported frequencies of TB clinic visits. 
Participants were also asked whether they were 
required to borrow money in order to meet the costs of 
treatment. Moreover, respondents were asked about 
other health care expenditure they had incurred during 
the previous month, such as expenditure on other 
providers (e.g. general practitioners in the private 
sector and traditional healers) and spending on self-
care (e.g. costs of special foods or costs of traditional 
medicines). By comparing these costs with the 
patient's reported overall monthly household 
expenditure, catastrophic health care expenditure was 
computed as expenditure on health care exceeding 
10% of total household expenditure. In respect of 
acceptability, participants were asked to report their 
perceptions of staff attitudes (whether they felt 
respected by staff and if the staff were too busy to 
answer their questions), the length of queues, facility 
cleanliness (inclusive of waiting areas and toilets), and 
community stigma (whether they felt that people in the 
community judge them negatively for attending the 
TB facility for their treatment).  
It is widely accepted that poor adherence to anti-
tuberculosis medications is one of the main barriers to 
global TB control [19]. Overall, there has been a range 
of approaches whereby adherence has been defined in 
different research and policy contexts. Adherence to 
medication can be described as the extent to which the 
patient’s history of remedial drug-taking matches the 
prescribed treatment regimen [19,20]. Assessment of 
adherence to treatment may also be outcome-oriented 
(using the final results of treatment as an index to 
measure success) or process-oriented (using the 
intermediate variables to measure adherence) [20]. In 
this analysis, the level of adherence is assessed 
through a process-oriented approach. Accordingly, the 
intermediate variables of having ever missed a TB 
clinic visit or missed a dose of TB medication is used 
as a proxy for non-adherence. Hence, in order to 
identify adherence status, patients were asked whether 
they had missed any clinic visits and/or any treatment 
doses. 
 
Study Setting & Sampling 
Four sub-districts were purposively selected and 
sampled by the REACH research team [17]. These 
sub-districts belonged to four provinces representing 
two rural (Bushbuckridge in Mpumalanga Province 
and Hlabisa in Northern KwaZulu Natal) as well as 
two urban settings (Mitchells Plain in the Cape 
Metropole, Western Cape Province; and Soweto in the 
City of Johannesburg, Gauteng Province). The logic of 
this selection was to reflect different geographic 
locations (rural-urban mix) as well as differences in 
governance contexts. In finalising the selection of sub-
districts, key officials in the national and provincial 
health departments were consulted. 
 A representative sample of 1229 TB patients was 
interviewed within 30 TB facilities across the four 
settings (approximately 300 participants per setting). 
In each sub-district, two-stage sampling was used: 
first, selecting a representative sample of primary 
health care facilities, then within chosen facilities, a 
representative sample of TB users [17]. Since most 
public health facilities in the country provide TB 
services, a minimum of five facilities were selected in 
each sub-district through the probability proportional 
to size (PPS) method, based upon the total number of 
TB users in each facility. Within selected facilities, a 
random sample of patients was interviewed until the 
proposed facility sample size was met. Respondents 
were eligible if they were over the age of 18, 
considered to be adequately well to be interviewed, 
and had been on TB treatment for at least eight weeks. 
After obtaining written informed consent from 
participants in the study, the interview was conducted 
by trained fieldworkers in the language of each 
subject’s choice. Ethical approval for the initial study, 
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of which this study is a sub-component, was obtained 
from ethics committees at the Universities of 
KwaZulu-Natal, Cape Town and Witwatersrand. 
Further permission to conduct the research was 
acquired from both provincial as well as local health 
authorities in South Africa.  
 
Data Analysis 
Data were analysed using Stata/IC 15.0. Summary 
statistics and cross-tabulations were used to describe 
socioeconomic, demographic as well as service-
related characteristics of male and female participants. 
Using the same method, the factors affecting access 
(inclusive of affordability, availability, and 
acceptability variables) were assessed relative to the 
gender of participants. Socioeconomic variables 
included employment, education and a composite 
asset index that allocated individuals to 
socioeconomic classes according to their household 
characteristics (such as type of house, toilet facility, 
walls, water supply, electricity for cooking, roof, etc.), 
and assets (including fridge, stove, DVD player, 
television, cell-phone, bicycle, etc.) [21,22]. The index 
was constructed using the multiple correspondence 
analysis (MCA). While the construction of asset 
indices is commonly achieved using principal 
components analysis (PCA), such a technique is more 
appropriate for use with continuous, normally 
distributed data as opposed to the predominantly 
categorical data often used in asset indices 
development [21-23]. 
Fisher's exact test or Mantel-Haenszel chi-square was  
used to compare the association between categorical 
variables. Furthermore, the association between 
continues variables was assessed applying the Mann–
Whitney U test (for medians) and Student's t-test (for 
means). A p-value less than 0.05 was accepted as 
statistically significant. Multivariate logistic and linear 
regressions were run in order to test the differences in 
access by gender as well as to assess the association 
between adherence level and gender, after controlling 
for age, socioeconomic status (asset index), level of 
education, employment status, setting, as well as 
duration on TB treatment. In this way, we can 
explicitly focus on gender-related access barriers and 
test inequality in these barriers by holding the other 
variables constant.   
 
Results  
 
Study sample characteristics  
Table 1 documents the socioeconomic, demographic, 
and service-related characteristics of the study 
participants, stratified by gender. The study sample 
had a balanced gender distribution (female 52.7%) 
and, as per the design of the study, approximately half 
were living in an urban setting (51.3%). The mean age 
of the participants was about 40 years and 35 years for 
males and females, respectively. As shown in Table 1, 
approximately one-quarter of participants were 
married or living with a partner (25.8%), one-sixth 
were employed (16.5%), about two-thirds were 
receiving a disability grant (73.72), and the majority of 
participants self-reported as African / black (94.8%). 
Compared with men, women had more years of 
schooling (p<0.001) and a greater chance of getting 
disability benefits (p<0.001). In contrast, a higher 
proportion of male participants reported that they were 
Table 1. Characteristics of TB users, in total and by sex. 
                                                  
 
Variables: 
All respondents 
       (n=1229) 
 
        Males 
(n=586;47.7%)  
       Females 
(n=643;52.3%) 
p-value 
Mean (median) age in years 37.35(36)  40.07(38) 34.87(33)              <0.001 
Married / living with partner (%) (vs 
single) 
25.81   36.69 15.89                 <0.001 
Respondent employed (%) 16.53  20.31 13.08                   0.001 
Mean (median) years of schooling 7.89(9)  7.36(8) 8.36(10)               <0.001 
Urban setting (%) 51.34  52.73 50.08                   0.353 
Receiving a disability grant (%) 73.72  66.72 80.09                 <0.001 
Asset index (% in poorest half) 50.04  48.98 51.01                   0.476 
African/black (%) (vs coloured and 
white) 
94.79  93.86 95.65                   0.159 
New patients (%) (vs re-treatment) 96.91  96.08 97.67                   0.107 
Clinic DOT (%) (vs others) 33.44  34.64 32.35                   0.699 
Adherents (%) (vs non-adherents) 82.02  81.57 82.43                   0.696 
Never missed TB doses (%) 85.44  84.81 86.00                   0.554 
Never missed TB visits (%) 86.57  86.18 86.94                   0.697 
     p-values computed using Wilcoxon-Mann-Whitney test for quantitative data; chi-squared goodness of fit test for binary data.
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employed (p=0.001), as well as married or living with 
a partner (p<0.001). There was no significant 
difference in the asset index, with men and women 
having similar asset-based wealth. 
Since the study sample is based on patients who 
attended primary health care centres, those with higher 
severity, who normally would be treated at secondary 
health care facilities, are less likely to have been 
included. Overall, the majority of participants were 
new TB patients (96.9%). Concerning the type of 
program, nearly one-third of respondents (33.4%) 
reported daily observed therapy at clinics (clinic 
DOT). Regarding adherence, 82% reported that they 
had never missed TB treatment (neither a single dose 
nor a visit), 84.8% of males and 86% of female 
patients reported they had never missed TB doses, 
similarly the proportions of the patients who never 
missed a TB visit were almost the same between 
(86.2% of males and 86.9% of females). Besides, the 
parameters inclusive of the type of treatment and type 
of patient (new or retreatment) were found not to be 
associated with gender. 
Gender differences in access to TB treatment 
Table 2 presents gender-level results of bivariate, 
unadjusted analysis and the multivariate analysis on 
each of the access variables involved in this study. The 
results of multivariate regressions are presented as 
coefficients or adjusted odds ratio (AOR). Considering 
female gender as the referent, these results summarise 
differences between male and female respondents 
across each dependent access variable, after 
controlling for age, sex, SES (asset index), level of 
education, employment status, and setting. 
In terms of availability, at the bivariate level, female 
participants on average spent more time travelling to 
the facilities than males whereby the average travel 
time for females was 36.4 minutes as compared to 34.5 
minutes for the males (p=0.012), although after 
adjustment for potential confounding variables the 
association did not reach statistical significance 
(p=0.342). With regards to waiting time at the clinic, 
females (89.5 minutes) spent a significantly higher 
average waiting time than male respondents (77.25 
minutes; p=0.002).  
With respect to affordability, male participants had 
significantly lower odds of getting disability benefits 
(AOR, 0.48; 95% CI, [0.36, 0.63]) and were more 
likely to spend money on other providers compared 
with women. As illustrated in table 2, the female 
participants were seen, on average, to spend more on 
the direct costs of seeking TB treatment, as well as 
other health care services during the past month when 
compared to the males. However, these inequalities in 
affordability by gender were not statistically 
significant (P-values > 0.05). Similarly, costs were 
catastrophic for a larger proportion of female 
respondents (33.98%) when compared to the males 
(31.9%), and a higher percentage of females borrowed 
money as a coping method to cover the health care 
expenditures (p=0.364). 
Concerning the acceptability dimension of access to 
TB services, approximately 31.8% of females agreed 
that queues were too long, compared to 23.9% of male 
participants (p=0.002) whereby male participants had 
a significantly lower odds of perceiving or 
experiencing long queues (AOR, 0.69; 95% CI, [0.52, 
0.91]). 
Additionally, regarding cleanliness, a higher 
percentage of female respondents (14%) agreed that 
the health facilities were dirty compared to males 
(9.6%) who had a lower odds of perceiving the 
facilities to be dirty (AOR, 0.67; 95% CI, [0.46, 0.97]). 
Being negatively judged as the result of attending TB 
clinics is used as a proxy for stigma in this study, 
where a slightly higher percentage of women (13.7%) 
reported that they had been judged for their TB status, 
when compared with men (12.7%); however, the 
association found not to be statistically significant 
(AOR, 0.97; 95% CI, [0.68, 1.38]). Regarding other 
acceptability-related variables, the results distinctly 
show that larger female proportion, as compared to 
male respondents, agreed that health workers were too 
busy to answer their questions and that some staff do 
not treat patients with sufficient respect; although 
these results were found not to be significantly 
associated with gender, even after adjustment for 
potential confounding variables. 
 
Adherence & gender differences in access to TB 
treatment 
As illustrated in Table 2, the results of multivariate 
analysis of the association between adherence status 
and gender reveals that there is no statistically 
significant association between being adherent and 
gender (AOR, 1.18; 95% CI, [0.86, 1.6]), as well as 
level of non-adherence (reporting missed visits and 
reporting missed doses) and gender (AOR, 1.2; 95% 
CI, [0.84, 1.75] and AOR, 1.2; 95% CI, [0.89, 1.76], 
respectively).  
Table 3 presents the results of the bivariate, unadjusted 
analysis of the association between each access 
dimension and gender, for different medication 
adherence levels. Overall, 82% (1008) of participants  
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Table 2. Access and adherence, by sex. (Controlling for age, SES, education, employment status, site, and duration on TB treatment) 
 Descriptive statistic                                     Regression                                            
 
 
      All respondents 
            (n=1229) 
 
Females 
(n=643;52.32%) 
Males 
(n=586;47.68%) 
p-value     AOR or 
estimated 
regression 
coefficient 
      p-value 95% Confidence 
interval 
variables :             
Availability  
Mean travelling time to 
the clinic (minutes) 
      35.48         36.40  34.48                0.012    - 1.70             0.342           (-5.22 , 1.81) 
Transport by foot (%) 56.64                       55.92  57.44                0.592      1.04             0.733        (0.81 , 1.34) 
Mean waiting time at 
clinic for doctor/nurse 
visit (minutes) 
83.62 89.51                           77.24                0.002    - 10.7             0.059 (         (- 22.01 , 0.42) 
Mean waiting time at 
clinic to collect TB 
medication (minutes)  
       34.7 37.62                      31.56                0.333     -7.06             0.029        (- 13.54 , - 0.70) 
Respondent receives 
clinic daily DOTs as 
service delivery model 
(%) 
        33.50 32.40  34.70                0.393       1.38             0.128        (0.91 , 2.10) 
Affordability             
Respondent receives a 
disability (chronic care) 
grant (%) 
73.72                       80.09   66.72               <0.001       0.48           <0.001        (0.36 , 0.63) 
Expenditure on other 
providers in the past 
month (ZAR) (mean) 
26.59                         26.31                             26.90                0.021     - 0.18             0.053
  
       (- 0.38 , 0.002) 
Expenditure on self-care 
in past month (ZAR) 
(mean) 
30.72 28.40                        33.25                0.892       0.09             0.347        (- 0.10 , 0.29) 
Expenditure to reach and 
during TB facility visits in 
past month (ZAR) (mean) 
42.44                          46.02  38.53                0.102     - 0.11             0.305        (- 0.33 , 0.10) 
Total expenditure on 
healthcare in past month 
(ZAR) (mean) 
99.77 100.66  98.79                0.305     - 0.01             0.875        (- 0.26 , 0.22) 
Households incurring 
healthcare costs >10% of 
household expenditure 
(%) 
32.99 33.98  31.90                0.468       0.93             0.652        (0.71 , 1.23) 
Respondent borrowed 
money to pay for 
healthcare in the past 
month (%) 
18.63 19.60  17.58                0.364       0.87             0.422        (0.63 , 1.20) 
Acceptability              
Respondent agrees that 
queues are too long (%) 
28.01 31.78  23.89                 0.002       0.69             0.009         (0.52 , 0.91) 
Respondent agrees that 
some staff do not treat 
patients with sufficient 
respect (%) 
19.09 20.87  17.12                 0.095       0.90             0.535         (0.67 , 1.22) 
Respondent agrees that 
the healthcare facility is 
dirty (%) 
11.09 14.00  9.59                   0.017       0.67             0.033         (0.46 , 0.97) 
`Respondent feels that 
people in the community 
judge him/her negatively 
for attending the TB 
facility (%) 
13.10 13.69  12.46                 0.524       0.97             0.877         (0.68 , 1.38) 
Respondent reports that 
health worker was too 
busy to answer their 
questions (%) 
10.99 11.20  10.77                  0.811       0.96             0.857         (0.66 , 1.40) 
Adherence         
Non-adherents (%) 17.98 17.57  18.43                 0.696       1.18             0.287        (0.86 , 1.62) 
Missed visits (%) 13.43 13.06  13.82                 0.697       1.20             0.296        (0.84 , 1.75)  
Missed doses (%) 14.56      14.00  15.19                 0.554       1.20             0.195        (0.89 , 1.76) 
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Table 3. Access and gender, at different adherence levels. 
 Never missed TB medication 
(n=1008; 82%) 
Respondents reporting missed 
visits (n=165; 13.4%)       
Respondents reporting missed 
doses* (n=179; 14.6%) 
   Males Females p-value   Males Females p-value Males Females p-value 
variables             
Availability           
Mean travelling time to 
the clinic (minutes) 
                  35.92 37.41  0.043   23.95   27.38      0.064  29.17            31.72 0.221 
Transport by foot (%)            55.14 53.40  0.580   74.07 65.48      0.230  64.04 70.79 0.337 
Mean waiting time at 
the clinic for 
doctor/nurse visit 
(minutes) 
          79.53 89.24  0.016   61.60 91.32      0.012  72.55 93.02 0.063 
Mean waiting time at 
the clinic to collect TB 
medication (minutes)  
           33.97 40.33  0.366   17.75 23.40      0.845  22.46 24.28 0.771 
Affordability           
Respondent receives a 
disability (chronic 
care) grant (%) 
          67.99 80.57 <0.001  60.49 79.75      0.007  60.67 76.67 0.021 
Expenditure on other 
providers in the past 
month (ZAR) 
         29.71 27.13   0.209    8.16 28.41      0.001  15.85 16.04 0.050 
Expenditure on self-
care in past month 
(ZAR) 
         35.57 31.68   0.690   3.89 5.71      0.423  27.58 13.33 0.171 
Expenditure to reach 
and during TB facility 
visits in past month 
(ZAR) 
        40.37 44.53   0.087 32.05 65.68      0.292  33.82 51.23 0.426 
Total expenditure on 
healthcare in the past 
month (ZAR) 
     105.66 103.56   0.529 44.25 100.22      0.031  77.27 78.02 0.830 
Households incurring 
healthcare costs >10% 
of household 
expenditure (%) 
       33.49 35.34   0.561 22.39 31.65      0.211  26.03 25.32 0.920 
Respondent borrowed 
money to pay for 
healthcare in the past 
month (%) 
      18.62 19.43   0.742  8.64 21.43      0.022  14.61 17.78 0.565 
Acceptability            
Respondent agrees that 
queues are too long 
(%) 
      23.22 30.38 0.011 29.63 38.55     0.228  28.09 38.20 0.152 
Respondent agrees that 
some staff do not treat 
patients with sufficient 
respect (%) 
      15.97 20.79 0.049 17.28 19.05     0.769  23.60 17.78 0.337 
Respondent agrees that 
the healthcare facility 
is dirty (%) 
      8.82 13.21 0.027 12.35 20.24     0.171  12.36 15.56  0.537 
Respondent feels that 
people in the 
community judge 
him/her negatively for 
attending the TB 
facility (%) 
     12.55 13.58 0.627 13.58 11.90     0.747  11.24 14.44 0.521 
* 123 participants (approximately 10 %) reported both missed visits and missed doses. 
 
met the criteria for adherence. Of those classified as 
non-adherent, 13.4% (165) reported missed visits and 
14.6% (179) reported missed doses (approximately 
10% of participants reported both missed visits and 
missed doses). In terms of availability (Table 3 and 
Figure 1), among those who were adherent to TB 
treatment, the mean travelling time reported by 
females (37.4 minutes) was significantly higher than 
male respondents (35.9 minutes). Similarly, among 
participants who reported missed visits mean   
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travelling time for females was significantly higher 
than males (27.4 versus 23.9 minutes, respectively). 
However, these findings may have less to do with the 
gender of patients than with the urban/rural setting as 
well as the service delivery model in those settings. 
Moreover, in both adherents and those who reported 
missed visits, females spent more waiting time at the 
clinic for health professional visit compared to men 
while this waiting time was slightly higher for female 
who reported missed visits (91.32 minutes) compared 
to adherent females (89.24 minutes).  
With regards to affordability, at all self-reported 
adherence levels, the proportion of females who 
received disability grants was higher than the males, 
although females in non-adherent groups (79.75% of 
those who ever missed a visit and 76.67% of those who 
ever missed a dose) were less likely to get disability 
benefit in comparison with adherent females 
(80.57%). The mean expenditure on other health care 
providers, which includes costs incurred from visiting 
general practitioners (GPs) or traditional healers, for 
adherent men (R 29.71) was higher than adherent 
females (R 27.13) albeit the association was not found 
to be statistically significant (p=0.209). Among non-
adherents, this expenditure was found to be 
significantly associated with gender, as women who 
reported missed visits (R 28.41) were seen to spend 
distinctly more on other providers than men (R 8.16).  
Borrowing money as a coping strategy to deal with TB 
treatment expenditures was found to be more common 
in females compared to male patients at any adherence 
level in this study. However, the association between 
borrowing money and gender was statistically 
significant only among patients who reported missing 
visits. About 21% of females compared with 8.6% of 
males borrowed money in order to cover the TB-
related expenditures (p=0.022). 
With respect to perceptions of the acceptability of TB 
services among adherent patients, statistically 
significant results (p=0.011) showed that higher 
proportion of females (about 30%) agreed that the 
queues were too long in comparison with male 
participants (about 23%). Identically, among non- 
adherent participants (both reporting missed visits and 
missed doses), the percentage of females who believed 
that queues were too long was higher than the 
percentage of males, although the association was not 
statistically significant. Generally, the association 
between non-  
 
Figure 1. Time commitments associated with using TB services 
in different adherence levels, by gender. 
 
adherence and length of queues were found not to be 
significant (AOR,1.2; 95% CI, [0.87, 1.7]). The 
association between adherence and cleanliness of 
facilities were found to be significant in the sample 
(AOR,1.7; 95% CI, [1.09, 2.69]). The participants who 
felt the facility is dirty were more likely to be non-
adherent to TB treatment. In addition, a higher 
proportion of adherent females (13.2%) reported that 
health facilities were dirty as compared with adherent 
males (8.8%). This difference was distinctly higher 
among those who have reported missing TB visits, 
where 20.2% of females versus 12.3% of males 
reported that facilities were dirty; however, the 
association is not statistically significant (p=0.171).  
  
Discussion  
This study has assessed gender-related differences in 
access to TB services from the perspective of users 
interviewed in 12 facilities within two rural and two 
urban health sub-districts in South Africa. Gender-
based inequalities in access barriers were appraised 
after controlling for differences in age, socioeconomic 
status (asset index), level of education, employment 
status, and site.  
Before interpreting the results, it is important to 
mention the limitations of this study. First, this analysis 
is based on subjects who have gained access to primary 
health care facilities and have used TB treatment. 
Therefore, it should be considered that access barriers 
might be different for those who have never gained 
entry to the facilities. Moreover, patients with severe 
and drug-resistant forms of TB, who usually are   
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seeking care at secondary level facilities, are less likely 
to have been part of the study population. Hence, the 
findings are narrowed to patient populations who could 
access primary care facilities. Secondly, adherence 
status is assessed in accordance with patient reports of 
missed treatment doses and clinic visits. Consequently, 
there is a potential for recall and reporting biases that 
may have over-estimated the level of adherence. Third, 
despite the great emphasis on the importance of 
evaluating both health system and patient level forces 
influencing access to health services, this study is based 
on patients' views on access barriers and the health 
worker perspectives on accessing TB services are not 
captured. Under this circumstance, a number of 
principal barriers to treatment access are not explored 
due to the limited scope of this study. Fourth, according 
to related literature, access barriers are likely to be 
context specific, hence results from the four included 
settings may not be generalizable to other countries. 
To our knowledge, this is the first study to explore 
gender-based inequalities in access to TB health care 
services in South Africa. Following the literature, TB 
can have associations with gender given that the social 
context can affect care-seeking behaviour, vulnerability 
to infection as well as treatment adherence [24]. In 
contrast, this study does not find much support for the 
association between gender and TB treatment access or 
adherence. With regards to the availability dimension 
of access, the only observed difference between men 
and women was the waiting time at the clinic to fetch 
TB medication. While not directly comparable, studies 
in Nepal [25], Bangladesh [26], and Viet Nam [27] 
found that women experience significantly longer 
diagnostic and TB treatment delays when compared to 
men. Moreover, women reported longer mean 
travelling time to the clinic. However, after controlling 
for other variables such as site, the difference was no 
longer significant. It might be explained by the fact that 
availability barriers are mostly context specific, hence 
after controlling for the variable “site”, we could not 
find significant inequalities between two genders in 
terms of travel time to the facility. Considering the 
affordability dimension of access, the only detected 
difference between the two genders was receiving the 
disability grant where women reported better access to 
the grant. This grant was available to patients who were 
unfit to work as a result of illness and who had an 
annual income below R29 112 for single people or R58 
224 for married people, at the time of primary data 
collection for REACH project. Based on the descriptive 
analysis of this study, a higher proportion of women 
were single and unemployed and therefore might face 
financial barriers to accessing TB services. In this way, 
we can argue that this difference in receiving disability 
grant may not be evidence of inequity between genders 
and may also mitigate the potential inequalities in 
affordability of services between men and women.  
While this study has revealed few associations between 
access and gender, findings concerning the 
acceptability dimension of access in this study show 
that there were differences between women and men in 
their perception of cleanliness of facilities as well as 
length of queues. We acknowledge that the data is old; 
however, it can be proven that our research findings are 
still useful. The data-set which is used for this analysis 
is based on the data from first-line TB patients who 
were on drug-sensitive TB treatment. Even though 
South Africa made considerable progress in TB control 
such as implementing new diagnostic tests (Xpert) and 
rolling out the latest second-line TB treatment 
programme in the past decade [4], the barriers of 
patients' access to TB services still remain.  
 
Conclusion  
This analysis has found very little evidence of gender-
related access inequalities to TB services and no 
association between the level of adherence to TB-
treatment and gender. However, the findings of this 
analysis reveal concerns about the condition and 
cleanliness of health facilities, which may be more of a 
barrier for women. This warrants a need to further 
explore the acceptability related factors of access to TB 
services, preferably by adopting both quantitative and 
qualitative approaches. 
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Differences in access to Tuberculosis services in 
South Africa 
Does gender matter? 
 
Executive summary  
The Tuberculosis (TB) epidemic is one of the significant public health 
challenges in South Africa. Although differences in access and 
adherence to TB treatment may have gender dimensions, these 
barriers to TB access have been an overlooked subject. This brief is 
from the paper “gender inequalities in access to Tuberculosis services 
in South Africa.” This policy brief provides an understanding of 
gender-related differences in adherence and access to TB health care 
services in South Africa, by analysing the adherence status as well as 
exploring the extent to which TB services are affordable, acceptable, 
and available to men and women. Findings suggest that access to TB-
treatment in South Africa is equitable for both genders. 
 
 
Introduction  
TB is the leading cause of mortality in 
South Africa and the country has the sixth-
highest TB burden in the world. Of every 
100 000 South Africans, 781 are expected 
to develop TB. Regardless of adoption of 
the Directly Observed Treatment, Short-
Course (DOTS) strategy since 1996 and 
considerable investments and 
improvement in TB control, South Africa 
has not met the TB-related targets set by 
the World Health Organization (WHO). The 
current burden of TB is expected to lead to 
mortality and morbidity in addition to 
substantial financial implications for the 
health system. Considering the infectious 
nature of TB as a communicable disease, 
for the sake of controlling the level and 
spread of the disease and preventing drug 
resistance, adherence to treatment is 
essential. Moreover, the burden of non-
adherence to TB treatment has been 
affirmed as one of the primary challenges 
facing global control of TB pandemic. The  
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Key points and policy 
implications: 
• In South Africa, levels of 
adherence to TB-treatment 
were found not to be 
associated with gender. 
• There was no evidence of 
systematic gender-based 
differences in access to TB 
services. 
• There exist concerns about 
the condition and cleanliness 
of health facilities that may 
impact the patients' adherence 
and be a barrier, particularly, in 
women’s use of TB services.  
• Improving the physical 
structure, layout, and the 
cleanliness of facilities are 
critical for achieving improved 
access to healthcare.  
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accessibility of needed care influences the 
adherence to treatment and in a situation in 
which non-adherence is the consequence of 
unjust and avoidable barriers, equity issue 
stresses its importance. Both barriers and 
facilitating factors to access and adherence to 
TB treatment are affected by different social 
determinants of health inclusive of gender.  
Even though the TB services are free at the 
point of use in South African public health  
 
facilities, much is unknown about overall 
barriers and gender-based inequalities in 
access to TB services and their association with 
TB treatment adherence. Reaching the WHO 
policy goal of reducing the TB incidence rate in 
South Africa to less than 167 cases per 100 000  
population and mortality to less than 9800 by 
the year 2030, requires an understanding of the 
nature of the barriers being faced by TB 
patients, regardless of their gender.
 
Findings  
Gender differences in access to TB treatment 
• Regarding affordability (financial access) 
of TB services, women were more likely to 
receive a disability grant. Although not 
statistically significant, the female participants 
were seen, on average, to spend more on the 
direct costs of seeking TB treatment, as well as 
other health care services during the past 
month and costs were catastrophic for a larger 
proportion of women when compared to the  
 
 
 
men. Also, a higher percentage of females 
borrowed money as a coping method to cover 
the healthcare expenditures. 
• Regarding availability (physical access) 
of TB services, men spent less time at the clinic 
to fetch TB medication. Moreover, female 
participants on average spent more time 
travelling to the facilities than males, yet this 
association was not statistically significant. 
Methods  
This study is a sub-component of the 
Researching Equity and Access to Health Care 
(REACH) project, a five-year multi-method study 
of equity in access to maternal deliveries, 
Antiretroviral Therapy (ART), and TB treatment 
in four South African provinces. 
 
 
During 2008/09, a representative sample of 1229 TB patients was interviewed within 30 TB facilities in 
two rural (Bushbuckridge in Mpumalanga Province and Hlabisa in Northern KwaZulu Natal) as well as 
two urban settings (Mitchells Plain in the Cape Metropole, Western Cape Province; and Soweto in the 
City of Johannesburg, Gauteng Province). Users were asked to report socioeconomic and demographic 
information along with information concerning key access barriers to TB-treatment. Respondents were 
considered ‘adherent’ if they reported having no missed visits or missed doses of TB-medication and 
they were considered ‘non-adherent’ if they reported having missed visits or missed doses of TB-
medication. 
www.sexrightsafrica.net 
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• Concerning the acceptability of TB 
services, women were less satisfied with the 
cleanliness of the facilities and the length of 
queues. 
 
Gender differences in access to TB treatment 
• Among the respondents, 82.4% of 
women and 81.6% of men reported being 
adherent to TB-treatment. There was no 
association between the level of adherence 
and gender. 
 
Adherence & gender differences in access to  
TB treatment 
• In terms of availability (Figure 1), among 
those who were adherent to TB treatment, the 
mean travelling time reported by females was 
significantly higher than male respondents. 
Similarly, among participants who reported 
missed visits, mean travelling time for females 
was significantly higher than males. 
Furthermore, in both adherents and those who 
reported missed visits, women spent more 
waiting time at the clinic for health 
professional visit compared to men while this 
waiting time was slightly higher for women 
who reported missed visits compared to 
adherent women. 
• Regarding affordability, at all self-
reported adherence levels, the proportion of 
women who received disability grants was 
higher than the men, although women in non-
adherent groups were less likely to get 
disability benefit in comparison with adherent 
women. 
• Concerning acceptability, the 
participants who felt the facility was dirty were 
more likely to be non-adherent to TB 
treatment. In addition, a higher proportion of 
adherent females reported that health 
facilities were dirty as compared with adherent 
males. 
 
Figure 1. Time commitments associated with using TB 
services in different adherence levels, by gender. 
 
What do these findings mean? 
These findings suggest little or no association 
between gender and barriers to accessing TB 
services, and no association between the level 
of adherence to TB-treatment and gender. 
However, the findings of this analysis reveal 
concerns about the condition and cleanliness of 
health facilities, which may be more of a barrier 
for women. 
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Appendices 
Appendix A: Patient Exit Interview Questionnaire for TB tracer, adopted from REACH report (Schneider 
et al., 2012). 
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Appendix B: Record Review of TB Services, adopted from REACH project (Schneider et al. , 2012). 
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Introduction 
Health Policy is intended to be a vehicle for the exploration and discussion of health policy issues 
and is aimed in particular at enhancing communication between health policy researchers, 
legislators, decision-makers and professionals concerned with developing, implementing, and 
analysing health policy in high-income countries primarily outside the US. 
Health care policies and reforms are made at an ever-increasing pace in countries around the 
world- and policy-makers are increasingly looking to other countries for solutions to their own 
problems. 
Health Policy is committed to support this international dialogue to ensure that policies are not 
just copied but used and adapted based on the specific problems and objectives as well as the 
respective context. Articles in Health Policy should thus describe and analyze 
1. what is happening in terms of policies, reforms, regulation etc. of health systems;
2. where are the ideas coming from, i.e. are they "imported" from another country or are they
developed within the country - and how innovative are they in comparison to what is happening
in other countries;
3. why is it happening, e.g. as a consequence of a change in government, popular dissatisfaction,
(perceived) unsustainable cost increases or an international requirement, and what are the
objectives;
4. the actors involved (both governmental as well as non-governmental including scientists, the
media and the public), what are their roles, their opinions and their strength in the decision and
implementation process;
5. intended and, especially, unintended effects of these policies or reforms on the health system
in terms of access, appropriateness, costs, effectiveness, quality, patient experience and equity
etc.; and last but not least
6. their final consequences in terms of health outcomes, financial protection and responsiveness
to the population's legitimate expectations, i.e. a performance assessment of reforms and health
systems.
To achieve the journal's objectives, authors are encouraged to write in a non-technical style, 
which is understandable to health policy practitioners and specialists from other disciplines. The 
use of overly technical tables (e.g. full of regression models) or equations is discouraged or should 
be placed in the supplementary material. 
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Types of Contribution 
Health Policy will be accepting submissions in three different formats: 
(1) "Health reform monitor" of around 2,500 to 3,000 words (excluding abstract and references),
concentrating on proposed, discussed, just passed and/ or implemented reforms in one of the
Health Systems and Policy Monitor member countries. These do not have to present empirical
data but analyze actors and processes. More information on Health Reform Monitor articles can
be found here.
(2) "Full-length articles" of around 4,000 words (excluding abstract and references and not more
than 4,500 words), mainly empirical, analyzing the impact of health systems, reforms and policies
- both in terms of intended and unintended effects. In addition, more theoretical, conceptual or
methodological papers can be submitted.
(3) "Reviews/comparative analyses" of around 6,000 words (excluding abstract and references
and not more than 7,000 words) can either be
(a) systematic reviews of health policy measures
(b) or examine certain aspects of health systems or health reforms in a systematic, comparative
1manner across a number of countries. Such papers may additionally include experience from
countries outside the primary focus of the journal.
In all cases, Authors should provide sufficient background and context and discuss their findings 
in an international context, to ensure that their manuscript can be appreciated by an 
international readership. 
Besides these three main types of submissions, Health Policy is interested in publishing debate 
among the readers in the form of letters and repliques as well as commissioned editorials. 
For all types of submissions, the material should not have been previously published in peer-
review journals elsewhere. Publication as an abstract, academic thesis or discussion paper is 
permissible but needs to be stated in the cover letter to the editor upon submission. 
Size and Layout 
Manuscripts should be written in English. They should be clear, concise and logical, and follow 
the suggested word length (see above) as well as the number of tables and figures (see below). 
Manuscripts should be structured as follows (if appropriate; e.g. Health Reform Monitor articles 
may differ): • Cover letter • Title Page (incl. Acknowledgements, e.g. to sponsors, and Conflict of 
Interest statement) • Abstract • Introduction • Materials and methods • Results • Discussion • 
Conclusions (especially for policy-makers and international audience) • Appendices (will be 
included as online supplementary material if the manuscript is accepted). 
There should be no footnotes or endnotes in the manuscript. 
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Manuscripts that do not comply with the above mentioned manuscript guidelines will be 
considered as non-admissible. All submissions will be checked for plagiarism. The handling editor 
will be informed about any incorrectly cited text passages/ findings of plagiarism. 
Figures, tables and equations 
Figures and tables are encouraged but should not be too technical. Technical tables and 
especially equations or other formulae should be avoided. Except in exceptional circumstances, 
the admissible number of figures and tables together is 2 for Health Reform Monitor articles, 4 
for full-length articles and 6 for reviews and comparative articles. Additional figures and tables 
may be supplied as supplementary material. Figures and tables should still be legible when 
reduced in size for printing. 
Essential title page information 
• Title. Be concise and informative. Titles are often used in information-retrieval systems. Avoid
abbreviations and formulae.
• Author names and affiliations. Where the family name may be ambiguous (e.g., a double name),
please indicate this clearly. Present the authors' affiliation addresses (where the actual work was
done) below the names. Indicate all affiliations with a lower-case superscript letter immediately
after the author's name and in front of the appropriate address. Provide the full postal address
of each affiliation, including the country name and, if available, the e-mail address of each author.
• Corresponding author. Clearly indicate who will handle correspondence at all stages of
refereeing and publication, also post-publication. Ensure that phone numbers (with country and
area code) are provided in addition to the e-mail address and the complete postal address.
Contact details must be kept up to date by the corresponding author.
• Present/permanent address. If an author has moved since the work described in the article was
done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated
as a footnote to that author's name. The address at which the author actually did the work must
be retained as the main, affiliation address. Superscript Arabic numerals are used for such
footnotes.
• Acknowledgements
• Conflict of Interest statement
Abstract 
An abstract of 200 words (and not more than 220) must be included in the submitted manuscript. 
As the abstract is often viewed separately from the article, it must be able to stand alone. It 
should state briefly and clearly the purpose and setting, the principal findings and major 
conclusions, and the paper's contribution to knowledge. If applicable, the 
country/countries/locations should be clearly stated, as should the methods and nature of the 
sample, the dates, and a summary of the findings/ conclusion. Please note that excessive 
statistical details should be avoided, abbreviations/acronyms used only if essential or firmly 
established, and the abstract should not contain references to other published work. 
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Classification and keywords 
Authors are asked to classify their submission using the provided classification system. They are 
also asked to include 3 to 6 keywords, preferably from the Medical Subject Headings from Index 
Medicus.  
Formatting of funding sources 
 List funding sources in this standard way to facilitate compliance to funder's requirements: 
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the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and the United States 
Institutes of Peace [grant number aaaa]. 
It is not necessary to include detailed descriptions on the program or type of grants and awards. 
When funding is from a block grant or other resources available to a university, college, or other 
research institution, submit the name of the institute or organization that provided the funding. 
If no funding has been provided for the research, please include the following sentence: 
This research did not receive any specific grant from funding agencies in the public, commercial, 
or not-for-profit sectors. 
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General points 
• Make sure you use uniform lettering and sizing of your original artwork.
• Embed the used fonts if the application provides that option.
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, Symbol,
or use fonts that look similar.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Size the illustrations close to the desired dimensions of the printed version.
• Submit each illustration as a separate file.
A detailed guide on electronic artwork is available on our website:
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Figure captions 
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. 
A caption should comprise a brief title (not on the figure itself) and a description of the 
illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and 
abbreviations used. 
Tables 
Number tables consecutively in accordance with their appearance in the text. Place footnotes to 
tables below the table body and indicate them with superscript lowercase letters. Avoid vertical 
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